Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	VAPA MYH6 CTTNBP2 CENPE SPATA31A7 TOGARAM1 NEB SPATA31A6 CEP350 SPTBN5 KIF2B MTUS1 ANLN STARD9 DIAPH3 MYO18B UTRN VPS18 LIMA1 SHROOM3 SPATA31A3 KTN1 MYRIP STMND1 SORBS1 APOE SPATA31A5 CLIP3 ABLIM1 PPP2R2A LRPPRC SPATA31A1 TIAM1 XIRP2 LMO7 MICAL2 PHACTR3 AATF CEP295 KIF13A PHACTR1	1.84e-08	1099	286	41	GO:0008092
GeneOntologyMolecularFunction	actin binding	MYH6 SPATA31A7 NEB SPATA31A6 SPTBN5 ANLN DIAPH3 MYO18B UTRN VPS18 LIMA1 SHROOM3 SPATA31A3 MYRIP SORBS1 SPATA31A5 ABLIM1 LRPPRC SPATA31A1 XIRP2 MICAL2 PHACTR3 PHACTR1	4.69e-07	479	286	23	GO:0003779
GeneOntologyMolecularFunction	endonuclease activity	ERCC4 ERCC5 ERVK-10 AGO4 AGO3 MBD4 PIWIL2 MBLAC1 EXO1	1.53e-04	136	286	9	GO:0004519
GeneOntologyMolecularFunction	phosphatase regulator activity	FRS2 PPP1R2B PPP1R35 PPP4R4 PPP2R2A PPP2R2B PHACTR3 PHACTR1	2.24e-04	113	286	8	GO:0019208
GeneOntologyBiologicalProcess	regulation of cell cycle process	UIMC1 PDE3A ATRX CENPE JADE1 UBXN2B KIF2B ANLN MKI67 TIMELESS PPP1R35 DIAPH3 MBD4 GPER1 WEE1 RBL1 USP28 AHCTF1 BRCC3 PIWIL2 MED1 MSX2 MBLAC1 MEPCE SMARCA2 WEE2 CEP295 DOT1L EIF4G3 KIF13A CSPP1 INS-IGF2	2.79e-07	845	286	32	GO:0010564
GeneOntologyBiologicalProcess	cell cycle process	UIMC1 PDE3A ERCC4 ATRX CENPE SDCCAG8 JADE1 FANCA UBXN2B AGO4 KIF2B ANLN STARD9 MKI67 TIMELESS PPP1R35 DIAPH3 MBD4 NIPBL TERB2 GPER1 WEE1 RBL1 USP28 AHCTF1 HAUS5 WRN BRCC3 PIWIL2 MED1 CCDC57 MSX2 MBLAC1 LMNA MEPCE SMARCA2 WEE2 CEP295 DOT1L EIF4G3 KIF13A CSPP1 INS-IGF2	1.58e-06	1441	286	43	GO:0022402
GeneOntologyBiologicalProcess	microtubule-based process	SLK ATRX CENPE SDCCAG8 ASH1L TOGARAM1 MECP2 IFT43 CEP350 PHLDB1 UBXN2B KIF2B STARD9 VPS13A PPP1R35 DIAPH3 PLTP CACNA1E LCA5 TRIM58 WEE1 KTN1 HAUS5 STMND1 CFAP43 CCDC57 WDPCP CLIP3 LRPPRC LMNA DAW1 CEP295 KIF13A RHOT1 DNAH11	1.74e-06	1058	286	35	GO:0007017
GeneOntologyBiologicalProcess	intracellular transport	VAPA SRPRA MECP2 IFT43 NUP205 NCBP3 SPTBN5 MALT1 STRADB C17orf75 EIF4ENIF1 UBR5 TBC1D14 VPS13A DIAPH3 DENND5A SNX12 AGAP3 LCA5 VPS18 GPER1 TRIM58 TNPO2 AHCTF1 EI24 MYRIP LMNB2 APOE MED1 WDPCP CLIP3 LRPPRC VPS13D LMNA DAW1 ANP32A LRP2 AKAP13 LTV1 LRBA ANP32D KIF13A RHOT1	4.13e-06	1496	286	43	GO:0046907
GeneOntologyBiologicalProcess	regulation of cell cycle	CDK16 UIMC1 PDE3A ATRX CENPE RNF40 JADE1 UBXN2B KIF2B ANLN MKI67 TIMELESS PPP1R35 DIAPH3 MBD4 GPER1 WEE1 RBL1 USP28 AHCTF1 SHB BRCC3 PIWIL2 MED1 CCDC57 MSX2 MBLAC1 MEPCE SMARCA2 AATF WEE2 CEP295 DOT1L EIF4G3 KIF13A CSPP1 INS-IGF2	1.22e-05	1256	286	37	GO:0051726
GeneOntologyBiologicalProcess	heterochromatin formation	ATRX MECP2 PHF2 UBR5 TDRD5 PIWIL2 LMNB2 RIF1 RESF1 LMNA DOT1L	1.79e-05	163	286	11	GO:0031507
GeneOntologyBiologicalProcess	microtubule-based movement	CENPE ASH1L MECP2 IFT43 KIF2B STARD9 VPS13A PLTP CACNA1E LCA5 TRIM58 KTN1 CFAP43 WDPCP CLIP3 LRPPRC DAW1 KIF13A RHOT1 DNAH11	2.00e-05	493	286	20	GO:0007018
GeneOntologyBiologicalProcess	nuclear transport	NUP205 NCBP3 MALT1 STRADB EIF4ENIF1 UBR5 AGAP3 GPER1 TNPO2 AHCTF1 EI24 MED1 LMNA ANP32A AKAP13 LTV1 ANP32D	2.34e-05	378	286	17	GO:0051169
GeneOntologyBiologicalProcess	nucleocytoplasmic transport	NUP205 NCBP3 MALT1 STRADB EIF4ENIF1 UBR5 AGAP3 GPER1 TNPO2 AHCTF1 EI24 MED1 LMNA ANP32A AKAP13 LTV1 ANP32D	2.34e-05	378	286	17	GO:0006913
GeneOntologyBiologicalProcess	presynaptic membrane organization	NLGN3 NLGN4X NLGN4Y APOE	2.35e-05	13	286	4	GO:0097090
GeneOntologyBiologicalProcess	regulation of organelle organization	PDE3A TBC1D9B ERCC4 ATRX CENPE SDCCAG8 TOGARAM1 NEB MECP2 SPTBN5 CRACD PHLDB1 TBC1D14 MKI67 KDR PPP1R35 DIAPH3 LIMA1 GPER1 HAUS5 STMND1 PIWIL2 WDPCP MSX2 RHOQ CLIP3 VPS13D RESF1 LMNA XIRP2 SMARCA2 AKAP13 WEE2 CEP295 EIF4G3 INS-IGF2 RHOT1	5.07e-05	1342	286	37	GO:0033043
GeneOntologyBiologicalProcess	heart development	MYH6 AHI1 FRS2 NEB MECP2 ALPK3 KDR MYO18B NIPBL MED12 COL11A1 GPER1 ID3 PCDHA10 MED1 MSX2 LMNA LBX1 XIRP2 MICAL2 VWA5A DAW1 LRP2 AKAP13 DNAH11	5.88e-05	757	286	25	GO:0007507
GeneOntologyBiologicalProcess	negative regulation of dendritic spine development	FSTL4 MECP2 NLGN3 APOE	9.50e-05	18	286	4	GO:0061000
GeneOntologyBiologicalProcess	negative regulation of gene expression, epigenetic	ATRX MECP2 PHF2 UBR5 TDRD5 PIWIL2 LMNB2 RIF1 RESF1 LMNA DOT1L	1.31e-04	203	286	11	GO:0045814
GeneOntologyBiologicalProcess	nucleus organization	KDM3A NUP205 PHF2 UBXN2B AGAP3 GPER1 AHCTF1 LMNB2 LMNA WEE2	1.36e-04	170	286	10	GO:0006997
GeneOntologyBiologicalProcess	enucleate erythrocyte development	DIAPH3 TRIM58 MED1	1.40e-04	8	286	3	GO:0048822
GeneOntologyBiologicalProcess	protein-DNA complex organization	UIMC1 KDM3A CAND1 ATRX CENPE ASH1L RNF40 JADE1 MECP2 PHF2 UBR5 MKI67 MED23 NIPBL TDRD5 SATB2 RBL1 BRCC3 ZDBF2 PIWIL2 LMNB2 MED1 RIF1 RESF1 BRF1 LMNA POLR1E SMARCA2 DOT1L	1.47e-04	999	286	29	GO:0071824
GeneOntologyBiologicalProcess	cardiac muscle tissue development	MYH6 FRS2 NEB MECP2 ALPK3 MYO18B COL11A1 MED1 MSX2 LMNA XIRP2 VWA5A LRP2 AKAP13	2.04e-04	327	286	14	GO:0048738
GeneOntologyBiologicalProcess	regulation of meiosis I	PIWIL2 WEE2 EIF4G3	2.08e-04	9	286	3	GO:0060631
GeneOntologyBiologicalProcess	microtubule-based transport	MECP2 IFT43 LCA5 TRIM58 CFAP43 WDPCP CLIP3 LRPPRC DAW1 KIF13A RHOT1 DNAH11	2.29e-04	253	286	12	GO:0099111
GeneOntologyBiologicalProcess	regulation of microtubule-based process	TOGARAM1 MECP2 PHLDB1 PPP1R35 DIAPH3 TRIM58 HAUS5 STMND1 CFAP43 CLIP3 CEP295 RHOT1 DNAH11	2.43e-04	293	286	13	GO:0032886
GeneOntologyBiologicalProcess	response to radiation	UIMC1 ERCC4 ERCC5 MECP2 NLGN3 MBD4 NIPBL AGAP3 KRAS CACNA1E COL6A3 TANK USP28 WRN EI24 BRCC3 LRP2 SPIDR	2.49e-04	503	286	18	GO:0009314
GeneOntologyBiologicalProcess	response to ionizing radiation	UIMC1 MECP2 NIPBL TANK USP28 WRN BRCC3 LRP2 SPIDR	2.65e-04	151	286	9	GO:0010212
GeneOntologyBiologicalProcess	organelle assembly	MYH6 TBC1D9B AHI1 CENPE ZNF423 SDCCAG8 TOGARAM1 NEB IFT43 CEP350 NLGN3 UBXN2B EIF4ENIF1 NEGR1 ANLN STARD9 TBC1D14 PPP1R35 DIAPH3 TCTN1 NPTX1 HAUS5 CFAP43 CCDC57 WDPCP ABLIM1 DAW1 AKAP13 WEE2 CEP295 LRBA	2.65e-04	1138	286	31	GO:0070925
GeneOntologyBiologicalProcess	presynaptic membrane assembly	NLGN3 NLGN4X NLGN4Y	2.95e-04	10	286	3	GO:0097105
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN3 NLGN4X NLGN4Y	9.93e-06	4	285	3	GO:0098983
GeneOntologyCellularComponent	supramolecular fiber	MYH6 CENPE TOGARAM1 POLR2M CMYA5 NEB RYR3 PARP4 KIF2B MTUS1 DIAPH3 MYO18B COL6A3 VPS18 SHROOM3 COL11A1 GPER1 HAUS5 LMNB2 APOE CCDC57 RHOQ CLIP3 LRPPRC LMNA TIAM1 XIRP2 MICAL2 AKAP13 CEP295 KIF13A CSPP1 RPL4 AHNAK2 DNAH11	1.28e-05	1179	285	35	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MYH6 CENPE TOGARAM1 POLR2M CMYA5 NEB RYR3 PARP4 KIF2B MTUS1 DIAPH3 MYO18B COL6A3 VPS18 SHROOM3 COL11A1 GPER1 HAUS5 LMNB2 APOE CCDC57 RHOQ CLIP3 LRPPRC LMNA TIAM1 XIRP2 MICAL2 AKAP13 CEP295 KIF13A CSPP1 RPL4 AHNAK2 DNAH11	1.48e-05	1187	285	35	GO:0099081
GeneOntologyCellularComponent	microtubule organizing center	AHI1 SDCCAG8 TENT5C TOGARAM1 UPF3B JADE1 MECP2 IFT43 CEP350 UBXN2B KIF2B MTUS1 STARD9 PPP1R35 DIAPH3 LCA5 HAUS5 WRN SORBS1 CCDC57 RESF1 TIAM1 DAW1 CKAP2L CEP295 KIF13A CSPP1	1.58e-04	919	285	27	GO:0005815
GeneOntologyCellularComponent	actin cytoskeleton	MYH6 CTTNBP2 POLR2M NEB ZYX SPTBN5 ANLN DIAPH3 MYO18B VPS18 LIMA1 SHROOM3 MYRIP SORBS1 RHOQ ABLIM1 XIRP2 MICAL2 AKAP13	3.78e-04	576	285	19	GO:0015629
GeneOntologyCellularComponent	nuclear periphery	NUP205 SATB2 AHCTF1 SORBS1 LMNB2 LMNA PHACTR3 ANP32A ANP32D	5.83e-04	171	285	9	GO:0034399
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	CENPE TOGARAM1 PARP4 KIF2B MTUS1 DIAPH3 MYO18B VPS18 SHROOM3 GPER1 HAUS5 LMNB2 APOE CCDC57 RHOQ CLIP3 LRPPRC LMNA TIAM1 MICAL2 AKAP13 CEP295 KIF13A CSPP1 DNAH11	6.20e-04	899	285	25	GO:0099513
GeneOntologyCellularComponent	symmetric synapse	NLGN3 NLGN4X NLGN4Y	6.48e-04	13	285	3	GO:0032280
HumanPheno	Prominent nasal bridge	AHI1 TRIO ZNF423 SDCCAG8 ASH1L TOGARAM1 UPF3B MECP2 HERC1 MED12 TCTN1 SATB2 TNPO2 WDPCP ASXL3 TBCK CKAP2L CEP295 CSPP1	1.23e-07	239	100	19	HP:0000426
HumanPheno	Abnormality of the testis size	ERCC4 ERCC5 ATRX SDCCAG8 TOGARAM1 UPF3B MECP2 FANCA TERB2 MED12 PDE11A NDNF SATB2 WRN BRCC3 WDPCP	1.24e-05	238	100	16	HP:0045058
HumanPheno	Hirsutism	ATRX TRIO SDCCAG8 NIPBL PDE11A LMNB2 WDPCP FRMD4A LRPPRC BCL11B LMNA ASXL3 TBCK CKAP2L KDSR	1.63e-05	216	100	15	HP:0001007
HumanPheno	Abnormal morphology of the nasal alae	AHI1 ERCC4 ERCC5 ATRX TRIO ZNF423 ASH1L TOGARAM1 MECP2 IFT43 SCNM1 MYO18B NIPBL MED12 TCTN1 KRAS SATB2 COL11A1 BRCC3 FRMD4A LRPPRC BRF1 ASXL3 TBCK SMARCA2 LRP2 CKAP2L CSPP1	2.27e-05	639	100	28	HP:0000429
HumanPheno	Lack of spontaneous play	MECP2 NLGN3 NLGN4X	2.90e-05	4	100	3	HP:0000721
HumanPheno	Abnormal play	MECP2 NLGN3 NLGN4X	2.90e-05	4	100	3	HP:5200104
HumanPheno	Abnormal enteric ganglion morphology	AHI1 ERCC4 ATRX ZNF423 SDCCAG8 TOGARAM1 FANCA TCTN1 KRAS WDPCP LBX1 CSPP1	3.08e-05	150	100	12	HP:0004362
HumanPheno	Megacolon	AHI1 ERCC4 ATRX ZNF423 SDCCAG8 TOGARAM1 FANCA TCTN1 KRAS WDPCP LBX1 CSPP1	3.08e-05	150	100	12	HP:6000852
HumanPheno	Aganglionic megacolon	AHI1 ERCC4 ATRX ZNF423 SDCCAG8 TOGARAM1 FANCA TCTN1 KRAS WDPCP LBX1 CSPP1	3.08e-05	150	100	12	HP:0002251
HumanPheno	Abnormal autonomic nervous system morphology	AHI1 ERCC4 ATRX ZNF423 SDCCAG8 TOGARAM1 FANCA TCTN1 KRAS WDPCP LBX1 CSPP1	3.29e-05	151	100	12	HP:0012331
HumanPheno	Abnormal enteric nervous system morphology	AHI1 ERCC4 ATRX ZNF423 SDCCAG8 TOGARAM1 FANCA TCTN1 KRAS WDPCP LBX1 CSPP1	3.29e-05	151	100	12	HP:0025028
HumanPheno	Low-set ears	AHI1 ERCC4 ERCC5 ATRX INTS1 ASH1L TOGARAM1 UPF3B NEB MECP2 SCNM1 MYO18B HERC1 NIPBL MED12 TCTN1 KRAS CACNA2D1 SATB2 COL11A1 BRCC3 FRMD4A LRPPRC BRF1 LMNA ASXL3 SMARCA2 LRP2 CSPP1 PHACTR1	8.21e-05	761	100	30	HP:0000369
HumanPheno	Increased serum serotonin	ATRX MECP2 NLGN3 NLGN4X	8.73e-05	13	100	4	HP:0003144
HumanPheno	Abnormal toe morphology	AHI1 ERCC4 ERCC5 DCAF8 TRIO CENPE ZNF423 INTS1 TOGARAM1 UPF3B MECP2 IFT43 RYR3 ITPR3 FANCA SCNM1 HERC1 NIPBL MED12 TCTN1 KRAS COL6A3 SATB2 COL11A1 WDPCP LMNA ASXL3 TBCK SMARCA2 CKAP2L CEP295 SPIDR CSPP1	1.15e-04	893	100	33	HP:0001780
HumanPheno	Inflexible adherence to routines	MECP2 NLGN3 NLGN4X	1.41e-04	6	100	3	HP:0000732
HumanPheno	Insistence on sameness	MECP2 NLGN3 NLGN4X	1.41e-04	6	100	3	HP:5200130
HumanPheno	Abnormal location of ears	AHI1 ERCC4 ERCC5 ATRX ZNF423 SDCCAG8 INTS1 ASH1L TOGARAM1 UPF3B NEB MECP2 SCNM1 MYO18B HERC1 NIPBL MED12 TCTN1 KRAS CACNA2D1 SATB2 COL11A1 BRCC3 WDPCP FRMD4A LRPPRC BCL11B BRF1 LMNA ASXL3 SMARCA2 LRP2 CSPP1 PHACTR1	1.49e-04	945	100	34	HP:0000357
HumanPheno	Highly arched eyebrow	AHI1 TRIO ZNF423 TOGARAM1 NIPBL TCTN1 FRMD4A LRPPRC ASXL3 TBCK SMARCA2 CEP295 CSPP1	1.68e-04	206	100	13	HP:0002553
HumanPheno	Abnormal hair morphology	AHI1 ERCC4 ERCC5 ATRX TRIO CENPE ZNF423 SDCCAG8 INTS1 ASH1L TOGARAM1 MECP2 IFT43 FANCA SCNM1 DENND5A MYO18B HERC1 NIPBL MED12 TCTN1 PDE11A KRAS SATB2 COL11A1 WRN BRCC3 LMNB2 APOE WDPCP FRMD4A LRPPRC BCL11B BRF1 LMNA ASXL3 TBCK SMARCA2 LRP2 CKAP2L CEP295 LTV1 SPIDR KDSR CSPP1	1.75e-04	1424	100	45	HP:0001595
HumanPheno	Abnormality of the outer ear	AHI1 ERCC4 ERCC5 ATRX TRIO CENPE ZNF423 SDCCAG8 INTS1 ASH1L TOGARAM1 UPF3B NEB MECP2 FANCA SCNM1 KDR DENND5A MYO18B HERC1 NIPBL MED12 TCTN1 KRAS CACNA2D1 SATB2 COL11A1 TNPO2 BRCC3 WDPCP MSX2 FRMD4A LRPPRC BCL11B BRF1 LMNA ASXL3 SMARCA2 LRP2 CEP295 KDSR CSPP1 PHACTR1	1.82e-04	1337	100	43	HP:0000356
HumanPheno	Abnormal external nose morphology	AHI1 ERCC4 ERCC5 ATRX TRIO CENPE ZNF423 INTS1 ASH1L TOGARAM1 MECP2 IFT43 SCNM1 MYO18B NIPBL MED12 TCTN1 KRAS SATB2 COL11A1 WRN BRCC3 FRMD4A LRPPRC BRF1 LMNA ASXL3 TBCK SMARCA2 LRP2 CKAP2L CEP295 CSPP1	1.91e-04	916	100	33	HP:0010938
HumanPheno	Abnormal pinna morphology	AHI1 ERCC4 ERCC5 ATRX TRIO CENPE ZNF423 SDCCAG8 INTS1 ASH1L TOGARAM1 UPF3B NEB MECP2 FANCA SCNM1 DENND5A MYO18B HERC1 NIPBL MED12 TCTN1 KRAS CACNA2D1 SATB2 COL11A1 TNPO2 BRCC3 WDPCP MSX2 FRMD4A LRPPRC BCL11B BRF1 LMNA ASXL3 SMARCA2 LRP2 CEP295 KDSR CSPP1 PHACTR1	2.03e-04	1299	100	42	HP:0000377
HumanPheno	Abnormal lower lip morphology	ERCC5 ATRX MECP2 IFT43 SCNM1 DENND5A MYO18B MED12 KRAS COL11A1 TNPO2 FRMD4A ASXL3 SMARCA2	2.32e-04	242	100	14	HP:0000178
HumanPheno	Narrow face	ERCC4 CENPE UPF3B NEB RYR3 MED12 SATB2 WRN LMNA	2.36e-04	108	100	9	HP:0000275
HumanPheno	Abnormal hair quantity	ERCC4 ERCC5 ATRX TRIO CENPE SDCCAG8 ASH1L TOGARAM1 MECP2 IFT43 NIPBL MED12 PDE11A KRAS SATB2 COL11A1 WRN LMNB2 APOE WDPCP FRMD4A LRPPRC BCL11B BRF1 LMNA ASXL3 TBCK SMARCA2 CKAP2L LTV1 SPIDR KDSR	2.49e-04	888	100	32	HP:0011362
Domain	DUF4599	SPATA31A7 SPATA31A6 SPATA31A3 SPATA31A5	2.29e-05	12	282	4	PF15371
Domain	DUF4599	SPATA31A7 SPATA31A6 SPATA31A3 SPATA31A5	2.29e-05	12	282	4	IPR027970
Domain	Nlgn	NLGN3 NLGN4X NLGN4Y	3.33e-05	5	282	3	IPR000460
Domain	DUF1785	AGO4 AGO3 PIWIL2	3.33e-05	5	282	3	SM01163
Domain	ArgoL1	AGO4 AGO3 PIWIL2	6.59e-05	6	282	3	PF08699
Domain	ArgoL1	AGO4 AGO3 PIWIL2	6.59e-05	6	282	3	IPR014811
Domain	HEAT_REPEAT	CAND1 TOGARAM1 NIPBL TNPO2 PPP4R4 MROH1 EIF4G3	8.83e-05	70	282	7	PS50077
Domain	Piwi	AGO4 AGO3 PIWIL2	1.80e-04	8	282	3	SM00950
Domain	Piwi	AGO4 AGO3 PIWIL2	1.80e-04	8	282	3	IPR003165
Domain	PIWI	AGO4 AGO3 PIWIL2	1.80e-04	8	282	3	PS50822
Domain	Piwi	AGO4 AGO3 PIWIL2	1.80e-04	8	282	3	PF02171
Domain	Wee1-like_protein_kinase	WEE1 WEE2	2.27e-04	2	282	2	IPR017164
Domain	NLGN4	NLGN4X NLGN4Y	2.27e-04	2	282	2	IPR030025
Domain	HEAT	CAND1 TOGARAM1 NIPBL TNPO2 MROH1 EIF4G3	2.35e-04	58	282	6	IPR000357
Domain	PAZ	AGO4 AGO3 PIWIL2	2.67e-04	9	282	3	SM00949
Domain	PAZ_dom	AGO4 AGO3 PIWIL2	2.67e-04	9	282	3	IPR003100
Domain	PAZ	AGO4 AGO3 PIWIL2	2.67e-04	9	282	3	PS50821
Domain	PAZ	AGO4 AGO3 PIWIL2	2.67e-04	9	282	3	PF02170
Domain	VPS13_N2	VPS13A VPS13D	6.75e-04	3	282	2	IPR031646
Domain	VPS13_mid_rpt	VPS13A VPS13D	6.75e-04	3	282	2	IPR031642
Domain	XPG_CS	ERCC5 EXO1	6.75e-04	3	282	2	IPR019974
Domain	VPS13	VPS13A VPS13D	6.75e-04	3	282	2	IPR026847
Domain	VPS13_mid_rpt	VPS13A VPS13D	6.75e-04	3	282	2	PF16910
Domain	VPS13	VPS13A VPS13D	6.75e-04	3	282	2	PF16908
Domain	AT_hook	ASH1L MECP2 AHCTF1 DOT1L	6.79e-04	27	282	4	SM00384
Domain	AT_hook_DNA-bd_motif	ASH1L MECP2 AHCTF1 DOT1L	6.79e-04	27	282	4	IPR017956
Domain	Carboxylesterase_B_CS	NLGN3 NLGN4X NLGN4Y	8.71e-04	13	282	3	IPR019819
Domain	COesterase	NLGN3 NLGN4X NLGN4Y	1.10e-03	14	282	3	PF00135
Domain	CARBOXYLESTERASE_B_2	NLGN3 NLGN4X NLGN4Y	1.10e-03	14	282	3	PS00941
Domain	CarbesteraseB	NLGN3 NLGN4X NLGN4Y	1.10e-03	14	282	3	IPR002018
Domain	FHA	PHLDB1 STARD9 MKI67 KIF13A	1.16e-03	31	282	4	PF00498
Domain	Pecanex_C	PCNX2 PCNX1	1.34e-03	4	282	2	PF05041
Domain	HhH2	ERCC5 EXO1	1.34e-03	4	282	2	IPR008918
Domain	PP2A_PR55	PPP2R2A PPP2R2B	1.34e-03	4	282	2	IPR000009
Domain	5-3_exonuclease_C	ERCC5 EXO1	1.34e-03	4	282	2	IPR020045
Domain	Argonaute_N	AGO4 AGO3	1.34e-03	4	282	2	IPR032474
Domain	Argonaute_Mid_dom	AGO4 AGO3	1.34e-03	4	282	2	IPR032473
Domain	ArgoL2	AGO4 AGO3	1.34e-03	4	282	2	IPR032472
Domain	VPS13_C	VPS13A VPS13D	1.34e-03	4	282	2	IPR031645
Domain	XPGN	ERCC5 EXO1	1.34e-03	4	282	2	SM00485
Domain	XPGI	ERCC5 EXO1	1.34e-03	4	282	2	SM00484
Domain	PR55_2	PPP2R2A PPP2R2B	1.34e-03	4	282	2	PS01025
Domain	PR55_1	PPP2R2A PPP2R2B	1.34e-03	4	282	2	PS01024
Domain	XPG_I	ERCC5 EXO1	1.34e-03	4	282	2	PF00867
Domain	XPG-I_dom	ERCC5 EXO1	1.34e-03	4	282	2	IPR006086
Domain	XPG/Rad2	ERCC5 EXO1	1.34e-03	4	282	2	IPR006084
Domain	PP2A_PR55_CS	PPP2R2A PPP2R2B	1.34e-03	4	282	2	IPR018067
Domain	SHR-BD	VPS13A VPS13D	1.34e-03	4	282	2	IPR009543
Domain	VPS13_C	VPS13A VPS13D	1.34e-03	4	282	2	PF16909
Domain	XPG_1	ERCC5 EXO1	1.34e-03	4	282	2	PS00841
Domain	XPG_2	ERCC5 EXO1	1.34e-03	4	282	2	PS00842
Domain	Pecanex	PCNX2 PCNX1	1.34e-03	4	282	2	IPR007735
Domain	ArgoN	AGO4 AGO3	1.34e-03	4	282	2	PF16486
Domain	ArgoMid	AGO4 AGO3	1.34e-03	4	282	2	PF16487
Domain	ArgoL2	AGO4 AGO3	1.34e-03	4	282	2	PF16488
Domain	SHR-BD	VPS13A VPS13D	1.34e-03	4	282	2	PF06650
Domain	HhH2	ERCC5 EXO1	1.34e-03	4	282	2	SM00279
Domain	AT_hook	MECP2 AHCTF1 DOT1L	1.65e-03	16	282	3	PF02178
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ABCC3 MRPL37 NEB ITPR3 CEP350 PARP4 PHLDB1 C17orf75 VPS13A GFPT2 NIPBL SATB2 WEE1 TNC KTN1 PON2 ZDBF2 MED1 PPP4R4 PPP2R2B POLR1E ASXL3 PHACTR3 SMARCA2 AATF CEP295 LTV1 MPHOSPH10 CSPP1 AHNAK2 DNAH11	4.24e-15	638	290	31	31182584
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDK16 TRIO SPATA18 ZYX CEP350 PHLDB1 MTUS1 ANLN STARD9 RABGAP1L UTRN AGAP3 LIMA1 SHROOM3 WEE1 BRCC3 SORBS1 PPP4R4 ABLIM1 LRPPRC VPS13D RESF1 TIAM1 LMO7 MEPCE EXO1 AKAP13 EIF4G3 KIF13A CSPP1 AHNAK2	1.09e-11	861	290	31	36931259
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A CAND1 DCAF8 ATRX TRIO CNST ZNF423 ASH1L RNF40 CMYA5 LRP1B ZKSCAN5 RYR3 CEP350 STAMBPL1 GFPT2 AMOTL2 MBD4 LNX1 UTRN NIPBL SDHA AGAP3 USP28 TNPO2 MYRIP BRCC3 SORBS1 APOE FAF1 ABLIM1 TIAM1 LMO7 MICAL2 LRP2 LRBA EIF4G3 RPL13	1.56e-11	1285	290	38	35914814
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CAND1 DCAF8 ATRX TRIO SDCCAG8 ASH1L PCNX2 PHF2 MALT1 NLGN3 PHLDB1 PTPRB HPCAL1 TBC1D14 OXSR1 DENND5A UTRN AGAP3 TRMT9B SHROOM3 NLGN4Y WDR70 SHB MYRIP PON2 CCDC57 FAF1 PPP4R4 ANKRD44 ABLIM1 PPP2R2A LRPPRC MICAL2 TBCK SMARCA2 AKAP13 ZFHX3 SPIDR LRBA EIF4G3 ZNF839	2.07e-11	1489	290	41	28611215
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A6 SPATA31A3 SPATA31A5 SPATA31A1	2.32e-10	6	290	5	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A6 SPATA31A3 SPATA31A5 SPATA31A1	2.32e-10	6	290	5	25930072
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CDK16 DCAF8 ETV3 POLR2M UPF3B PALMD TYSND1 ZYX CEP350 MALT1 PHLDB1 EIF4ENIF1 AGO3 UBR5 HPCAL1 TBC1D14 ARHGAP29 C19orf44 PPP1R35 DIAPH3 AMOTL2 MED12 WEE1 HAUS5 WDR70 CLASRP ABLIM1 PPP2R2A AATF LTV1 ARHGEF3 RPL4	2.56e-10	1038	290	32	26673895
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CENPE SRPRA NEB SPATA31A6 RYR3 NCBP3 PHLDB1 PTPRB KIF2B HERC1 MED12 KTN1 SORBS1 APOE CCDC57 VPS13D XIRP2 LMO7 MEPCE LRBA CSPP1 CDH7	2.78e-10	497	290	22	36774506
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VAPA UIMC1 MYH6 ERCC5 ATRX SLCO2B1 ASH1L CLPX NEB MECP2 NUP205 HPCAL1 STARD9 VPS13A KDR DIAPH3 NIPBL CACNA1E LIMA1 PPFIA4 KTN1 SHB MYRIP LMNB2 CCDC57 PPP4R4 LRPPRC LMNA LMO7 ANKRD30A AATF CEP295 MPHOSPH10 EIF4G3 RPL4 RPL13	5.21e-09	1442	290	36	35575683
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	UIMC1 SLK CAND1 ATRX MRPL37 UPF3B ZYX CRACD PPP1R2B MKI67 UTRN NIPBL LIMA1 USP28 AHCTF1 GPATCH1 KTN1 WDR70 MED1 RIF1 ABLIM1 MEPCE LTV1 LRBA EIF4G3 RPL4 RPL13 AHNAK2	6.61e-09	934	290	28	33916271
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	UIMC1 KDM3A SRPRA RNF40 ZYX ANLN OXSR1 MED23 LIMA1 SATB2 WDR70 BRCC3 CPS1 MED1 ABLIM1 RESF1 LMNA VWA5A AHNAK2	8.17e-09	444	290	19	34795231
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH6 SLK CAND1 CTTNBP2 TRIO UPF3B MECP2 CRACD NLGN3 DLGAP3 PHLDB1 NEGR1 UTRN SDHA AGAP3 CACNA2D1 VPS18 LIMA1 TNC PPFIA4 KTN1 SORBS1 APOE RIN1 ABLIM1 PPP2R2A LRPPRC LMNA LMO7 MICAL2 EIF4G3 RPL4 RHOT1 RPL13 DNAH11	1.45e-08	1431	290	35	37142655
Pubmed	Defining the membrane proteome of NK cells.	ABHD17A KDM3A CAND1 CENPE CNST INTS1 RNF40 TYSND1 NUP205 ITPR3 CEP350 PARP4 AGO4 EIF4ENIF1 AGO3 UBR5 MKI67 STAMBPL1 MED12 KRAS KTN1 EI24 APOE MED1 LRPPRC AKAP13 LRBA KDSR RPL4 RHOT1 RPL13	1.66e-08	1168	290	31	19946888
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	VAPA CDK16 AHI1 ATRX SDCCAG8 ZYX IFT43 NUP205 EIF4ENIF1 RABGAP1L PLCL2 TCTN1 AGAP3 LCA5 LIMA1 TSC22D3 WEE1 RBL1 KTN1 WDR70 WRN EI24 MED1 CLASRP RIN1 RIF1 ABLIM1 PPP2R2A LRPPRC TIAM1 LMO7 LTV1 CSPP1	2.36e-08	1321	290	33	27173435
Pubmed	Tagging genes with cassette-exchange sites.	VAPA ZNF423 JADE1 MALT1 RABGAP1L MKI67 OXSR1 MED23 LIMA1 TNPO2 RIF1 PPP2R2A RESF1 BRF1 AKAP13 AATF	2.80e-08	335	290	16	15741177
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A7 SPATA31A6 MYO18B SPATA31A3 SPATA31A5 SPATA31A1	3.79e-08	24	290	6	32212159
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	VAPA UIMC1 ATRX INTS1 SRPRA RNF40 MECP2 ITPR3 FANCA PHF2 MKI67 MBD4 NIPBL CASP8AP2 ZSCAN5A AHCTF1 GPATCH1 KTN1 WRN EI24 BRCC3 LMNB2 MED1 CLASRP RIF1 LMNA LMO7 POLR1E EXO1 AATF RPL4 RPL13	4.93e-08	1294	290	32	30804502
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CDK16 CTTNBP2 SRPRA EIF4ENIF1 UBR5 AMOTL2 UTRN AGAP3 LIMA1 SHROOM3 SORBS1 ANKRD44 ABLIM1 PPP2R2A LMO7 EXO1 CEP295 CSPP1	4.94e-08	446	290	18	24255178
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 TBC1D9B TRIO INTS1 RNF40 JADE1 ITPR3 FANCA PCNX2 PHLDB1 EIF4ENIF1 C19orf44 DENND5A HERC1 MED12 SDHA AGAP3 SHROOM3 WDR70 LMNB2 CFAP43 MSX2 MROH1 PCNX1 AKAP13 LRBA DOT1L ZNF839 AHNAK2	6.30e-08	1105	290	29	35748872
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CAND1 WWC3 BSPRY UPF3B ITPR3 MKI67 OXSR1 AMOTL2 MED12 SDHA KRAS VPS18 LIMA1 KTN1 APOE MED1 RHOQ ABLIM1 PPP2R2A LRPPRC ELL2 LMNA LMO7 MICAL2 ANP32A MEPCE SMARCA2 MPHOSPH10 DOT1L RPL4 RPL13	7.22e-08	1247	290	31	27684187
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CENPE INTS1 FRS2 SRPRA NUP205 FANCA IGSF10 PARP4 SAMD9L ZFR2 TBC1D14 VPS13A AMOTL2 UTRN SDHA TNPO2 KTN1 PIWIL2 LMNB2 LMNA LRP2 AKAP13 CEP295	7.51e-08	736	290	23	29676528
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	UIMC1 KDM3A CNST UBXN2B MTUS1 ANLN STARD9 MKI67 LIMA1 AHCTF1 BRCC3 RIF1 LMO7 AKAP13 RPL4 RPL13	7.82e-08	361	290	16	30344098
Pubmed	A "double adaptor" method for improved shotgun library construction.	CEP350 MALT1 DLGAP3 C17orf75 UBXN2B HPCAL1 VPS13A HERC1 PLTP TSC22D3 EI24 MFSD9 CCDC57 WDPCP RIF1 LRPPRC VPS13D TIAM1 MICAL2 ANP32A	9.75e-08	574	290	20	8619474
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	VAPA UIMC1 KDM3A SLK CAND1 CTTNBP2 RNF40 UPF3B TYSND1 CLPX NUP205 UBXN2B UBR5 STAMBPL1 UTRN RBM45 USP28 KTN1 WDR70 WRN BRCC3 FAF1 LRPPRC POLR1E MEPCE SMARCA2 EIF4G3	1.16e-07	1005	290	27	19615732
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KDM3A CAND1 RNF40 JADE1 NUP205 AGO4 MTUS1 OXSR1 AMOTL2 MED23 CASP8AP2 SATB2 SHROOM3 SDK2 USP28 HAUS5 PPP2R2A LMO7 PCNX1	1.29e-07	529	290	19	14621295
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AHI1 ERCC4 ERCC5 ATRX CNST ASH1L JADE1 NLGN3 ANLN PLCL2 TIMELESS GFPT2 HERC1 UTRN UBE2Q2 LRRC18 AHCTF1 RESF1 TCP11L2 TYW1B LRP2 AATF CEP295 MPHOSPH10 ARHGEF3 DOT1L KIF13A PHACTR1	1.49e-07	1084	290	28	11544199
Pubmed	Aurora B opposes PP1 function in mitosis by phosphorylating the conserved PP1-binding RVxF motif in PP1 regulatory proteins.	UBR5 MKI67 AHCTF1 RIF1 MPHOSPH10	1.58e-07	16	290	5	29764992
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SLK CAND1 CTTNBP2 TRIO CENPE TRPC4 NLGN3 DLGAP3 AGO3 UBR5 NIPBL KRAS CACNA1E CACNA2D1 LIMA1 SHROOM3 ZNRD2 USP28 KTN1 GRIK3 SORBS1 LMNB2 ABLIM1 LRPPRC BCL11B PHACTR1	1.83e-07	963	290	26	28671696
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF8 ASH1L CLPX MECP2 ZKSCAN5 PHF2 MALT1 EIF4ENIF1 AGO3 MTUS1 UBR5 STK39 AGAP3 WEE1 RBL1 AHCTF1 HAUS5 PPP2R2A BCL11B RESF1 LBX1 POLR1E MEPCE SMARCA2 LRP2 ZFHX3 CEP295 RHOT1	2.68e-07	1116	290	28	31753913
Pubmed	Large-scale concatenation cDNA sequencing.	CEP350 MALT1 DLGAP3 C17orf75 UBXN2B HPCAL1 VPS13A HERC1 PLTP TSC22D3 EI24 MFSD9 CCDC57 WDPCP RIF1 LRPPRC VPS13D MICAL2 ANP32A	3.81e-07	568	290	19	9110174
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	VAPA SLK SRPRA ZYX ITPR3 PPP1R2B LPCAT2 UBR5 VPS13A LIMA1 AHCTF1 KTN1 EI24 ZDBF2 LMNB2 VPS13D LMNA LRBA AHNAK2	3.81e-07	568	290	19	37774976
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN3 NLGN4X NLGN4Y	5.74e-07	3	290	3	32011705
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN3 NLGN4X NLGN4Y	5.74e-07	3	290	3	18628683
Pubmed	Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.	MECP2 NLGN3 NLGN4X NLGN4Y	5.77e-07	9	290	4	23010509
Pubmed	ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain.	ATRX MKI67 SATB2 BCL11B	5.77e-07	9	290	4	25395668
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FANCA DLGAP3 VPS13A MKI67 MYO18B SNX12 PPFIA4 MYRIP PCDHA10 RGS20 LRP2 LRBA KIF13A RPL13	8.33e-07	329	290	14	17474147
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	CAND1 RYR3 MED12 LIMA1 SHROOM3 PPP2R2A PPP2R2B LMNA TIAM1 LMO7 RHOT1	8.42e-07	195	290	11	17110338
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	CDK16 ANLN MKI67 AHCTF1 GPATCH1 WDR70 LMNB2 RIF1 LMNA	8.60e-07	121	290	9	22412018
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TRIO CENPE SDCCAG8 LRP1B NUP205 CEP350 EIF4ENIF1 AGO3 MTUS1 UBR5 ARHGAP29 LCA5 SHROOM3 TANK GPATCH1 HAUS5 SHB SORBS1 CCDC57 COMMD2 LRP2 CEP295 LTV1	9.80e-07	853	290	23	28718761
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A SLK ZYX ANLN DIAPH3 AMOTL2 MED23 MED12 LIMA1 AHCTF1 KTN1 HAUS5 APOE MED1 ABLIM1 LMO7 LRBA DOT1L	1.03e-06	549	290	18	38280479
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TBC1D9B CTTNBP2 SLCO2B1 TOGARAM1 ZKSCAN5 CEP350 PHF2 NLGN3 PARP4 SAMD9L MED12 VPS18 PPFIA4 KTN1 PPP4R4 VPS13D SPIDR	1.05e-06	493	290	17	15368895
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	UIMC1 KDM3A ATRX INTS1 MECP2 NCBP3 PHF2 ANLN MKI67 TIMELESS MBD4 NIPBL AHCTF1 WDR70 WRN MED1 RIF1 POLR1E DOT1L	1.05e-06	608	290	19	36089195
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ERCC4 ATRX RNF40 NUP205 ITPR3 UBR5 MKI67 GFPT2 MED23 WEE1 GPATCH1 MED1 LMNA SMARCA2 AATF MPHOSPH10	1.10e-06	440	290	16	34244565
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CTTNBP2 TRIO CMYA5 NEB STRADB PARP4 MYO18B UTRN COL6A3 KTN1 SHB SORBS1 FAF1 ABLIM1 LRPPRC LMNA XIRP2	1.17e-06	497	290	17	23414517
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	VAPA UIMC1 CAND1 ATRX INTS1 SRPRA MECP2 PHF2 CRACD EIF4ENIF1 ANLN MED23 MBD4 UTRN NIPBL MED12 SDHA AGAP3 SHROOM3 ZNRD2 AHCTF1 KTN1 WRN MED1 RIF1 ABLIM1 POLR1E SMARCA2 AATF ZFHX3 MPHOSPH10 EIF4G3	1.22e-06	1497	290	32	31527615
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PDE3A ZYX ANLN MKI67 TIMELESS STK39 NIPBL AGAP3 AHCTF1 MED1 RIN1 RIF1 LMNA LMO7 AKAP13 EIF4G3 KIF13A	1.37e-06	503	290	17	16964243
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	VAPA UIMC1 DCAF8 BSPRY FRS2 NEB NCBP3 TYROBP NLGN3 C17orf75 KDR TIMELESS MBD4 TCTN1 CACNA1E CASP8AP2 CACNA2D1 LIMA1 ZNRD2 TNC WRN ID3 BRCC3 CPS1 MED1 FRMD4A PPP2R2B MEPCE ANKRD30A	1.57e-06	1293	290	29	15342556
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	UIMC1 CENPE MRPL37 CRACD GFPT2 LIMA1 FAF1 BRF1 TIAM1 ANKRD30A	1.83e-06	170	290	10	23314748
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CTTNBP2 INTS1 NUP205 CEP350 AGO3 UBR5 MKI67 HERC1 UTRN SDHA LIMA1 ANKRD44 RIF1 PPP2R2A LRPPRC PPP2R2B PHACTR3 RPL4	1.89e-06	573	290	18	28330616
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	CAND1 CENPE UPF3B NUP205 NCBP3 MKI67 MED23 MED12 KTN1 WRN MED1 RIF1 POLR1E EXO1 CKAP2L AATF LTV1 MPHOSPH10 EIF4G3 RPL4 RPL13	1.97e-06	759	290	21	35915203
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN3 NLGN4X NLGN4Y	2.28e-06	4	290	3	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN3 NLGN4X NLGN4Y	2.28e-06	4	290	3	22671294
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN3 NLGN4X NLGN4Y	2.28e-06	4	290	3	20579107
Pubmed	BCL11B expression in intramembranous osteogenesis during murine craniofacial suture development.	MKI67 SATB2 BCL11B	2.28e-06	4	290	3	25511173
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN3 NLGN4X NLGN4Y	2.28e-06	4	290	3	16077734
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN3 NLGN4X NLGN4Y	2.28e-06	4	290	3	17292328
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CENPE TOGARAM1 UPF3B PHLDB1 SAMD9L MYO18B SDK2 WDR70 CLASRP LMNA LMO7 ASXL3 AKAP13 RPL13	2.47e-06	361	290	14	26167880
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UIMC1 KDM3A ERCC5 ATRX MECP2 ZYX ANLN MKI67 TIMELESS OXSR1 NIPBL LIMA1 WEE1 MED1 CLASRP RIF1 ABLIM1 LMNA LMO7 SMARCA2 EXO1	2.67e-06	774	290	21	15302935
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	INTS1 NUP205 ITPR3 UBR5 MKI67 UTRN NIPBL MED12 SDHA AHCTF1 LMNB2 RIF1 LRPPRC LMNA SMARCA2 AATF MPHOSPH10 EIF4G3 RPL4	2.98e-06	653	290	19	22586326
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	VAPA CDK16 CAND1 TRIO SRPRA CLPX MECP2 ZYX NUP205 ARHGAP29 UTRN SDHA AGAP3 ZNRD2 RBL1 LMNB2 RIF1 ABLIM1 LMNA TIAM1 ANP32A AKAP13 ARHGEF3	3.22e-06	916	290	23	32203420
Pubmed	Novel interactors and a role for supervillin in early cytokinesis.	ATRX STARD9 LIMA1 LMNB2 LMNA	3.27e-06	28	290	5	20309963
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	CAND1 PUS3 ATRX RNF40 UBR5 MKI67 MYO18B UTRN AGAP3 USP28 KTN1 RIF1 LRPPRC MEPCE RPL4 RPL13 AHNAK2	3.38e-06	538	290	17	28524877
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SLK SRPRA ZYX CEP350 PARP4 EIF4ENIF1 AGO3 LPCAT2 MKI67 OXSR1 DIAPH3 KTN1 MED1 PPP2R2A LMO7 AKAP13 AATF MPHOSPH10 EIF4G3 AHNAK2	3.55e-06	724	290	20	36232890
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	PDE3A CENPE NEB KDR HERC1 SDHA LIMA1 SDK2 LTV1 LRBA KIF13A	4.93e-06	234	290	11	36243803
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	UIMC1 CAND1 ATRX INTS1 RNF40 NUP205 UBR5 MKI67 OXSR1 MED23 MBD4 NIPBL MED12 CASP8AP2 USP28 WDR70 LMNB2 MED1 RIF1 PPP2R2A POLR1E ANP32A MEPCE SMARCA2	5.33e-06	1014	290	24	32416067
Pubmed	Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.	CACNA1E SATB2 SHB BCL11B PCNX1	5.54e-06	31	290	5	27321927
Pubmed	Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2.	LMNB2 BCL11B LMNA	5.67e-06	5	290	3	24672053
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN3 NLGN4X NLGN4Y	5.67e-06	5	290	3	10996085
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN3 NLGN4X NLGN4Y	5.67e-06	5	290	3	37865312
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	INTS1 ASH1L STARD9 TBC1D14 ALPK3 STAMBPL1 CASP8AP2 SORBS1 FRMD4A	6.01e-06	153	290	9	10718198
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	RNF40 NUP205 PHLDB1 UBR5 MKI67 MED23 SDHA MAP3K19 KRAS CASP8AP2 SHROOM3 COL11A1 RBL1 EI24 LMNB2 CLIP3 POLR1E MPHOSPH10 KIF13A RPL13	6.47e-06	754	290	20	35906200
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	KDM3A ZYX CRACD ANLN MKI67 UTRN LIMA1 SATB2 AHCTF1 WDR70 SORBS1 MED1 RIF1 LMO7 MEPCE CKAP2L	6.52e-06	506	290	16	30890647
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	INTS1 CEP350 EIF4ENIF1 MED12 VPS18 GPATCH1 HAUS5 MEPCE LTV1 LRBA EIF4G3	6.79e-06	242	290	11	34011540
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CDK16 CLPX ANLN SATB2 RBL1 TNPO2 LRPPRC BCL11B RESF1 SMARCA2 AATF DOT1L RPL4 RPL13	7.54e-06	398	290	14	35016035
Pubmed	A protein interaction landscape of breast cancer.	CDK16 UIMC1 CAND1 TRIO CLPX ITPR3 STRADB UBR5 MKI67 AMOTL2 MBD4 USP28 BRCC3 RIN1 LRPPRC MICAL2 SMARCA2 RPL4	7.60e-06	634	290	18	34591612
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TRIO ITPR3 PARP4 WRN MED1 TIAM1 SMARCA2 ANKRD30A AKAP13 RPL4	8.48e-06	202	290	10	33005030
Pubmed	alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus.	ERCC4 ERCC5 FANCA LMNA SMARCA2	8.89e-06	34	290	5	16889989
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	TRIO ZYX MKI67 SDHA LIMA1 EI24 CPS1 LMNA LRBA RPL4 RPL13 AHNAK2	8.90e-06	298	290	12	30737378
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	ABCC3 ERCC4 ERCC5 FANCA KDR MBD4 KRAS TNC RBL1 WRN EXO1 RGS17 CDH12	9.26e-06	351	290	13	20453000
Pubmed	Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons.	MKI67 LMNB2 BCL11B LMNA	1.03e-05	17	290	4	21976703
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	VAPA UIMC1 SLK CAND1 RNF40 UPF3B LPCAT2 RABGAP1L UTRN NIPBL SDHA LIMA1 HAUS5 BRCC3 PPP2R2A COMMD2 SMARCA2 LTV1 EIF4G3 RPL4 RPL13	1.05e-05	847	290	21	35235311
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	CAND1 ERCC4 ATRX CEP350 UBR5 MKI67 MED23 GPATCH1 WDR70 PPP2R2A LMNA RPL4 RPL13	1.11e-05	357	290	13	37059091
Pubmed	The mouse orthologue of the human ionotropic glutamate receptor-like gene (GRINL1A) maps(1) to mouse chromosome 9.	POLR2M ANP32A ANP32D	1.13e-05	6	290	3	12063408
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN3 NLGN4X NLGN4Y	1.13e-05	6	290	3	21838267
Pubmed	Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration.	LMNB2 BCL11B LMNA	1.13e-05	6	290	3	23650370
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN3 NLGN4X NLGN4Y	1.13e-05	6	290	3	29724786
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO CEP350 EIF4ENIF1 MTUS1 UBR5 ARHGAP29 UTRN ZDBF2 VPS13D LTV1	1.14e-05	209	290	10	36779422
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	UIMC1 TRIO MECP2 NCBP3 ANLN MED12 USP28 MED1 RIN1 RIF1 ABLIM1 PPP2R2A SMARCA2 CKAP2L MPHOSPH10	1.20e-05	472	290	15	38943005
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SLK ITPR3 PTPRB ANLN STK39 UTRN NIPBL LIMA1 KTN1 LMNB2 LMNA LMO7 AHNAK2	1.21e-05	360	290	13	33111431
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	VAPA TRIO CNST SRPRA PALMD LRP1B PPP1R2B DLGAP3 HPCAL1 RABGAP1L SDHA AGAP3 KTN1 ZDBF2 SORBS1 FRMD4A ABLIM1 LRPPRC LMNA COMMD2 ANP32A ANP32D EIF4G3 RPL13 PHACTR1	1.22e-05	1139	290	25	36417873
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	ATRX SPATA18 RYR3 IGSF10 SHROOM3 RIF1 MICAL2 AKAP13 PHACTR1	1.28e-05	168	290	9	30631154
Pubmed	Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.	UIMC1 ATRX CASP8AP2 FAF1 PPP2R2A	1.56e-05	38	290	5	28680062
Pubmed	Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala.	MKI67 SATB2 BCL11B ASXL3 CDH12	1.56e-05	38	290	5	38086370
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	TRIO ARHGAP29 TIAM1 AKAP13 ARHGEF3	1.56e-05	38	290	5	19911011
Pubmed	ARX regulates cortical intermediate progenitor cell expansion and upper layer neuron formation through repression of Cdkn1c.	MKI67 SATB2 ID3 BCL11B	1.66e-05	19	290	4	23968833
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CAND1 INTS1 NUP205 NCBP3 ITPR3 CEP350 PHLDB1 UBR5 MKI67 UTRN NIPBL CACNA2D1 LIMA1 HAUS5 LMNB2 RIF1 ABLIM1 LRPPRC LMNA LMO7 CKAP2L AATF RPL13	1.93e-05	1024	290	23	24711643
Pubmed	K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks.	UIMC1 FANCA BRCC3	1.96e-05	7	290	3	25132264
Pubmed	S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.	MKI67 BCL11B SMARCA2	1.96e-05	7	290	3	23359715
Pubmed	Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation.	MED23 MED12 MED1	1.96e-05	7	290	3	18691967
Pubmed	AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.	MKI67 KRAS AATF	1.96e-05	7	290	3	29321668
Interaction	YWHAG interactions	VAPA CDK16 SLK SPATA18 CEP350 CRACD PHLDB1 MTUS1 HPCAL1 ANLN STARD9 RABGAP1L ARHGAP29 KDR AMOTL2 LNX1 UTRN SDHA AGAP3 KRAS LCA5 LIMA1 SHROOM3 WEE1 SHB BRCC3 SORBS1 FAF1 PPP4R4 RIN1 FRMD4A ABLIM1 VPS13D LMNA TIAM1 LMO7 MEPCE EXO1 AKAP13 LRBA EIF4G3 KIF13A CSPP1 AHNAK2	2.10e-08	1248	286	44	int:YWHAG
Interaction	YWHAH interactions	VAPA CDK16 TRIO SPATA18 CEP350 PHLDB1 MTUS1 HPCAL1 ANLN STARD9 RABGAP1L AMOTL2 HERC1 UTRN AGAP3 KRAS LCA5 LIMA1 SHROOM3 WEE1 BRCC3 SORBS1 MED1 FAF1 PPP4R4 RIN1 FRMD4A ABLIM1 VPS13D RESF1 TIAM1 LMO7 MEPCE EXO1 AKAP13 LRBA EIF4G3 CSPP1 AHNAK2	1.34e-07	1102	286	39	int:YWHAH
Interaction	NR3C1 interactions	ABCC3 MRPL37 NEB ITPR3 CEP350 PARP4 PHLDB1 C17orf75 ANLN VPS13A GFPT2 NIPBL CASP8AP2 SATB2 WEE1 TNC KTN1 PON2 BRCC3 ZDBF2 MED1 PPP4R4 MSX2 LRPPRC PPP2R2B POLR1E ASXL3 PHACTR3 SMARCA2 AATF CEP295 LTV1 MPHOSPH10 CSPP1 AHNAK2 DNAH11	1.50e-07	974	286	36	int:NR3C1
Interaction	NINL interactions	AHI1 CENPE SDCCAG8 RNF40 CEP350 EIF4ENIF1 AGO3 MTUS1 UBR5 DIAPH3 LCA5 GPATCH1 HAUS5 CCDC57 ABLIM1 LRPPRC LMNA LMO7 COMMD2 ANP32A ZFHX3 CEP295 CSPP1	1.82e-07	458	286	23	int:NINL
Interaction	NUP43 interactions	KDM3A ERCC5 ASH1L MECP2 NCBP3 PHF2 EIF4ENIF1 UBR5 MKI67 TIMELESS NIPBL MED12 CASP8AP2 AHCTF1 GPATCH1 WRN ZDBF2 RIF1 RESF1 LMNA POLR1E AATF ZFHX3 MPHOSPH10 EIF4G3 AHNAK2	1.06e-06	625	286	26	int:NUP43
Interaction	YWHAB interactions	VAPA CDK16 SLK CENPE SPATA18 NEB ZYX CEP350 PHLDB1 HPCAL1 ANLN STARD9 AMOTL2 LNX1 SDHA AGAP3 KRAS LCA5 LIMA1 SHROOM3 WEE1 SORBS1 PPP4R4 RIN1 ABLIM1 VPS13D TIAM1 LMO7 MEPCE EXO1 AKAP13 DOT1L IKBKB AHNAK2	3.05e-06	1014	286	34	int:YWHAB
Interaction	YWHAE interactions	VAPA CDK16 AHI1 CAND1 CENPE SPATA18 TENT5C ZYX CRACD DLGAP3 PHLDB1 HPCAL1 ANLN AMOTL2 SDHA AGAP3 KRAS LCA5 LIMA1 SHROOM3 KTN1 SORBS1 CFAP43 FAF1 PPP4R4 MSX2 RHOQ RIN1 FRMD4A ABLIM1 TIAM1 LMO7 MEPCE EXO1 AKAP13 LRBA DOT1L ZNF839 RPL4	3.46e-06	1256	286	39	int:YWHAE
Interaction	YWHAZ interactions	VAPA CDK16 SLK BSPRY SPATA18 TENT5C SRPRA NEB CRACD PHLDB1 MTUS1 HPCAL1 ANLN STARD9 ARHGAP29 LNX1 SDHA KRAS LCA5 LIMA1 SHROOM3 WEE1 SORBS1 APOE FAF1 PPP4R4 MSX2 RHOQ RIN1 ABLIM1 LRPPRC VPS13D LMNA TIAM1 LMO7 ASXL3 MEPCE EXO1 AKAP13 ZNF839	4.52e-06	1319	286	40	int:YWHAZ
Interaction	SFN interactions	SLK JADE1 NEB CEP350 PHLDB1 MTUS1 ANLN RABGAP1L OXSR1 KRAS LIMA1 SHROOM3 WEE1 SORBS1 PPP4R4 ABLIM1 PPP2R2B LMNA TIAM1 LMO7 EXO1 AKAP13 KIF13A RPL4 RPL13 AHNAK2	6.75e-06	692	286	26	int:SFN
Interaction	PPP1CC interactions	UIMC1 KDM3A CNST MECP2 PPP1R2B UBXN2B MTUS1 UBR5 ANLN STARD9 PLCL2 MKI67 PPP1R35 KRAS LIMA1 AHCTF1 BRCC3 ZDBF2 RHOQ RIF1 LMNA LMO7 PHACTR3 AKAP13 DOT1L RPL4 RPL13	7.24e-06	738	286	27	int:PPP1CC
Interaction	FBXO22 interactions	CENPE SRPRA NEB SPATA31A6 RYR3 NCBP3 PHLDB1 PTPRB KIF2B HERC1 MED12 KTN1 SORBS1 APOE CCDC57 VPS13D XIRP2 LMO7 MEPCE LRBA CSPP1 CDH7	1.02e-05	540	286	22	int:FBXO22
Interaction	OFD1 interactions	AHI1 CENPE SDCCAG8 CEP350 EIF4ENIF1 ANLN DIAPH3 LCA5 TANK USP28 GPATCH1 HAUS5 CCDC57 ELL2 COMMD2 CEP295 CSPP1	1.04e-05	347	286	17	int:OFD1
Interaction	KIF20A interactions	CENPE NUP205 PCNX2 SAMD9L AGO4 EIF4ENIF1 AGO3 UBR5 ANLN RABGAP1L MKI67 HERC1 MBD4 UTRN LIMA1 SHROOM3 ZNRD2 AHCTF1 KTN1 HAUS5 PIWIL2 LMNB2 CPS1 ABLIM1 LRPPRC BRF1 LMNA LMO7 SMARCA2 KIF13A RPL4 RPL13 AHNAK2	1.70e-05	1052	286	33	int:KIF20A
Interaction	CEP128 interactions	SPATA18 NUP205 CEP350 EIF4ENIF1 ARHGAP29 SDHA TANK GPATCH1 HAUS5 ZDBF2 SORBS1 ABLIM1 LMO7 LTV1 CSPP1	2.44e-05	297	286	15	int:CEP128
Interaction	IMP3 interactions	ATRX MECP2 ZYX ANLN MKI67 KRAS AATF MPHOSPH10 DOT1L RPL13	2.66e-05	137	286	10	int:IMP3
Interaction	CIT interactions	INTS1 ASH1L SRPRA RNF40 UPF3B CLPX CMYA5 ZYX NUP205 ITPR3 PHF2 ANLN MKI67 OXSR1 HERC1 LNX1 NIPBL SDHA LIMA1 USP28 TNPO2 AHCTF1 KTN1 LMNB2 CFAP43 CPS1 MED1 RIF1 ABLIM1 LRPPRC LMNA LMO7 MEPCE SMARCA2 AATF MPHOSPH10 CSPP1 RPL4 RPL13 AHNAK2	4.04e-05	1450	286	40	int:CIT
Interaction	YWHAQ interactions	VAPA CDK16 PDE3A SLK SPATA18 NEB CEP350 PHLDB1 MTUS1 ANLN STARD9 AMOTL2 LNX1 SDHA KRAS LCA5 LIMA1 SHROOM3 WEE1 SORBS1 CPS1 MED1 PPP4R4 ABLIM1 LRPPRC VPS13D LMNA TIAM1 LMO7 MEPCE EXO1 AKAP13 LRBA	5.66e-05	1118	286	33	int:YWHAQ
Interaction	DHX40 interactions	ERCC5 NCBP3 PHF2 UBR5 HERC1 ZNRD2 KTN1 ZDBF2 LMNB2 LMNA MEPCE AATF MPHOSPH10	6.05e-05	249	286	13	int:DHX40
Interaction	PML interactions	UIMC1 KDM3A ERCC4 ATRX SRPRA ZYX NUP205 UBR5 ANLN TBC1D14 STK39 OXSR1 MED23 AGAP3 KRAS CASP8AP2 LIMA1 WDR70 WRN BRCC3 MED1 ABLIM1 LRPPRC LMNA LMO7 VWA5A RPL4 RPL13 AHNAK2	6.70e-05	933	286	29	int:PML
Interaction	SENP6 interactions	ATRX KRAS ZDBF2 LMNA TIAM1 EXO1	7.29e-05	50	286	6	int:SENP6
Interaction	KCTD13 interactions	MYH6 SLK CAND1 CTTNBP2 TRIO UPF3B MECP2 CRACD NLGN3 DLGAP3 PHLDB1 NEGR1 GFPT2 LNX1 UTRN SDHA AGAP3 CACNA2D1 VPS18 LIMA1 TNC PPFIA4 KTN1 SORBS1 APOE FAF1 RIN1 ABLIM1 PPP2R2A LRPPRC LMNA LMO7 MICAL2 EIF4G3 RPL4 RHOT1 RPL13 DNAH11	8.23e-05	1394	286	38	int:KCTD13
Interaction	MED4 interactions	SLK AHI1 CENPE POLR2M RNF40 ZYX CEP350 UBR5 MED23 UTRN MED12 KRAS LCA5 HAUS5 MED1 POLR1E LRBA CSPP1	8.35e-05	450	286	18	int:MED4
Interaction	ZC3H13 interactions	MYH6 RNF40 MECP2 NCBP3 ANLN MED23 MED12 KRAS MED1 DOT1L	8.94e-05	158	286	10	int:ZC3H13
Interaction	SPICE1 interactions	MYH6 SRPRA ZYX CEP350 MTUS1 DIAPH3 HAUS5 CKAP2L CEP295 LTV1 CSPP1	9.37e-05	191	286	11	int:SPICE1
Interaction	BRCA1 interactions	CDK16 UIMC1 CAND1 ERCC4 ERCC5 TRIO ZNF423 POLR2M CLPX FANCA CEP350 PARP4 AGO3 UBR5 ANLN MKI67 HERC1 NIPBL MED12 SDK2 RBM45 WEE1 RBL1 USP28 WRN BRCC3 ANKRD44 RIF1 LMNA MICAL2 SMARCA2 EXO1 AATF IKBKB RPL4	9.41e-05	1249	286	35	int:BRCA1
Interaction	EIF3B interactions	VAPA ATRX UPF3B MECP2 CEP350 EIF4ENIF1 ANLN MKI67 KRAS KTN1 PHACTR3 MEPCE DOT1L EIF4G3 RPL13	1.02e-04	337	286	15	int:EIF3B
Interaction	SNRNP40 interactions	KDM3A MECP2 EIF4ENIF1 UBR5 ANLN MKI67 MED12 KRAS CASP8AP2 RBL1 AHCTF1 GPATCH1 WRN ZDBF2 CLASRP LMNA POLR1E MEPCE AATF ZFHX3 MPHOSPH10 DOT1L	1.21e-04	637	286	22	int:SNRNP40
Interaction	RPS7 interactions	CAND1 ATRX SRPRA UPF3B MECP2 EIF4ENIF1 ANLN KRAS LCA5 RBM45 APOE LMNA ASXL3 MEPCE MPHOSPH10 DOT1L RPL4 RPL13	1.29e-04	466	286	18	int:RPS7
Interaction	NRBP1 interactions	SLK BPGM KRAS LIMA1 TSC22D3 RIF1 LRPPRC TIAM1 LRBA	1.35e-04	135	286	9	int:NRBP1
Cytoband	2q24-q31	TANK LRP2	1.19e-04	3	290	2	2q24-q31
GeneFamily	LIM domain containing	ZYX LIMA1 ABLIM1 XIRP2 LMO7 MICAL2	2.77e-05	59	182	6	1218
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG TRIO FSTL4 IGSF10 NEGR1 ALPK3 KDR SDK2 SIGLEC11	3.74e-05	161	182	9	593
GeneFamily	Argonaute/PIWI family	AGO4 AGO3 PIWIL2	5.41e-05	8	182	3	408
GeneFamily	Lamins	LMNB2 LMNA	3.00e-04	3	182	2	612
GeneFamily	Phosphatase and actin regulators	PHACTR3 PHACTR1	5.97e-04	4	182	2	679
GeneFamily	ANP32 acidic nuclear phosphoproteins	ANP32A ANP32D	9.88e-04	5	182	2	27
GeneFamily	Kinesins\|Pleckstrin homology domain containing	CENPE KIF2B STARD9 KIF13A	1.17e-03	46	182	4	622
GeneFamily	WD repeat domain containing	AHI1 DCAF8 HERC1 WDR70 CFAP43 PPP2R2A PPP2R2B DAW1 LRBA	1.38e-03	262	182	9	362
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	UIMC1 BRCC3	1.47e-03	6	182	2	1328
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC4 ERCC5	2.05e-03	7	182	2	1268
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CENPE CNST ITPR3 MKI67 PPP1R35 PHACTR3 MPHOSPH10	2.41e-03	181	182	7	694
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC4 ERCC5	2.71e-03	8	182	2	1125
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 MYRIP AKAP13	3.02e-03	29	182	3	396
GeneFamily	Cyclins\|Mediator complex	MED23 MED12 MED1	4.38e-03	33	182	3	1061
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO TIAM1 AKAP13 ARHGEF3	4.41e-03	66	182	4	722
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	MECP2 MBD4	5.22e-03	11	182	2	1025
GeneFamily	EF-hand domain containing	TBC1D9B FSTL4 RYR3 LPCAT2 HPCAL1 CACNA1E RHOT1	6.82e-03	219	182	7	863
GeneFamily	Low density lipoprotein receptors	LRP1B LRP2	7.31e-03	13	182	2	634
GeneFamily	CD molecules\|Type II classical cadherins	CDH7 CDH12	7.31e-03	13	182	2	1186
GeneFamily	UBX domain containing	UBXN2B FAF1	7.31e-03	13	182	2	364
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A SLK CAND1 ATRX TRIO CENPE TOGARAM1 MECP2 CEP350 MALT1 UBR5 HPCAL1 RABGAP1L VPS13A ARHGAP29 STK39 OXSR1 DENND5A NIPBL TPST1 SATB2 TANK AHCTF1 SHB WRN ID3 MED1 RIF1 PPP2R2A LRPPRC ELL2 RGS20 TIAM1 MICAL2 SMARCA2 AKAP13 ZFHX3 SPIDR EIF4G3	4.11e-14	856	285	39	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	SLK AHI1 CTTNBP2 ERCC5 LAYN CENPE CEP350 MTUS1 ANLN RABGAP1L MKI67 DIAPH3 MBD4 NIPBL CASP8AP2 LIMA1 AHCTF1 KTN1 WRN BRCC3 RIF1 RESF1 SMARCA2 MPHOSPH10 CSPP1 ZNF654	1.66e-08	656	285	26	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SLK ATRX TRIO CENPE MECP2 CEP350 UBR5 VPS13A ARHGAP29 STK39 OXSR1 DENND5A SATB2 SHB WRN PPP2R2A LRPPRC RGS20 TIAM1 SMARCA2 EIF4G3	4.94e-08	466	285	21	M13522
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PRTG ERCC4 TRIO MECP2 NLGN3 PHLDB1 SAMD9L AGO4 NEGR1 RABGAP1L TBC1D14 DENND5A AMOTL2 PDGFC NDNF COL6A3 CACNA2D1 COL11A1 SHB WRN SORBS1 ANKRD44 CLIP3 ABLIM1 PPP2R2A PPP2R2B TCP11L2 VWA5A SMARCA2 PCNX1 ZFHX3 CEP295 KIF13A	1.56e-07	1102	285	33	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PRTG ERCC4 TRIO MECP2 NLGN3 PHLDB1 SAMD9L AGO4 NEGR1 RABGAP1L TBC1D14 DENND5A AMOTL2 PDGFC NDNF COL6A3 CACNA2D1 COL11A1 SHB WRN SORBS1 ANKRD44 CLIP3 ABLIM1 PPP2R2A PPP2R2B TCP11L2 VWA5A SMARCA2 PCNX1 ZFHX3 CEP295 KIF13A	2.44e-07	1124	285	33	MM1070
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ABHD17A SLK WWC3 ATRX ASH1L SRPRA JADE1 MECP2 ZYX CEP350 PCNX2 TYROBP MALT1 SAMD9L UBR5 RABGAP1L HERC1 UTRN NIPBL TANK TSC22D3 KTN1 CPA3 MED1 ANKRD44 RIF1 PPP2R2B BCL11B RESF1 VWA5A SMARCA2 PCNX1 AKAP13 ARHGEF3 LRBA RPL4 RPL13	2.56e-06	1492	285	37	M40023
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	AHI1 TRIO SDCCAG8 MTUS1 NIPBL TPST1 TBCK ARHGEF3 SPIDR LRBA EIF4G3	2.62e-06	169	285	11	M39230
Coexpression	ZHENG_BOUND_BY_FOXP3	KDM3A FRS2 ETV3 TENT5C TLR8 MALT1 RABGAP1L DENND5A UTRN NIPBL COL11A1 RBL1 ANKRD44 ABLIM1 BCL11B AKAP13 ARHGEF3 KDSR	1.01e-05	498	285	18	M1741
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP	SRPRA MALT1 MED12 LMNB2 FAF1 LRPPRC PHACTR3 ANP32A MEPCE AKAP13 RPL4	1.08e-05	196	285	11	M7973
Coexpression	ZHENG_BOUND_BY_FOXP3	KDM3A FRS2 ETV3 TENT5C TLR8 MALT1 RABGAP1L DENND5A UTRN NIPBL COL11A1 RBL1 ANKRD44 ABLIM1 BCL11B AKAP13 ARHGEF3 KDSR	1.28e-05	507	285	18	MM1030
Coexpression	GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	CDK16 KDM3A CLPX HPCAL1 PLTP COL6A3 SHROOM3 APOE LRPPRC LMO7 ARHGEF3	1.31e-05	200	285	11	M8217
Coexpression	GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP	UIMC1 ERCC4 ASH1L TENT5C UPF3B TBC1D14 EI24 APOE ELL2 MEPCE RHOT1	1.31e-05	200	285	11	M8528
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN	HERC1 TIAM1 ZFHX3 SPIDR LRBA EIF4G3	1.67e-05	50	285	6	M5077
Coexpression	BENPORATH_OCT4_TARGETS	KDM3A JADE1 ZKSCAN5 UBR5 KDR MED12 CACNA2D1 WEE1 TNC WDR70 SORBS1 RIF1 RESF1	1.95e-05	290	285	13	M17183
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE	ABCC3 PDE3A CNST TENT5C IGSF10 STRADB VPS13A PPP1R35 HERC1 PDGFC LCA5 LIMA1 TRIM58 AHCTF1 PRR7 ABLIM1 LMNA XIRP2 VWA5A ARHGEF3 LRBA	2.69e-05	694	285	21	M45731
Coexpression	HUANG_DASATINIB_SENSITIVITY_UP	LAYN ZYX SAMD9L ARHGAP29 PDGFC LIMA1 ELL2	2.69e-05	80	285	7	M3015
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	LAYN CENPE THSD1 FANCA PHLDB1 ANLN MKI67 TIMELESS DIAPH3 WEE1 RBL1 ID3 PPP4R4 BCL11B LMO7 DAW1 EXO1 CKAP2L PHACTR1	2.71e-05	588	285	19	M38992
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ATRX TOGARAM1 MECP2 CEP350 MTUS1 UBR5 RABGAP1L VPS13A MKI67 WEE1 RIF1 MICAL2 MPHOSPH10	2.78e-05	300	285	13	M8702
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ATRX NEB LRP1B UBXN2B NLGN4X MTUS1 NEGR1 RABGAP1L HERC1 UBE2Q2 PDE11A CACNA1E COL11A1 TRIM58 PPFIA4 GRIK3 SORBS1 ANKRD44 PPP2R2B BCL11B BRF1 VWA5A ASXL3 PHACTR3 RGS17 ZFHX3 KIF13A AHNAK2	3.23e-05	1106	285	28	M39071
Coexpression	BENPORATH_NANOG_TARGETS	CDK16 UIMC1 KDM3A CAND1 WWC3 MRPL37 JADE1 RYR3 FANCA SCNM1 EIF4ENIF1 UBR5 KDR MED23 MED12 CACNA2D1 WEE1 TNC SORBS1 RIF1 ELL2 RESF1 TIAM1 VWA5A ANP32A LRP2	3.29e-05	988	285	26	M6616
Coexpression	BROWNE_HCMV_INFECTION_10HR_DN	PARP4 MTUS1 ARHGAP29 NIPBL RGS20 ANP32A	3.57e-05	57	285	6	M8416
Coexpression	CUI_TCF21_TARGETS_2_DN	SLK CTTNBP2 ASH1L FRS2 POLR2M JADE1 MALT1 PPP1R2B PARP4 PTPRB AGO4 MTUS1 RABGAP1L VPS13A ARHGAP29 MED23 UBE2Q2 SHROOM3 PON2 SORBS1 ELL2 TCP11L2 LMO7 LRBA	4.40e-05	888	285	24	MM1018
Coexpression	ENK_UV_RESPONSE_EPIDERMIS_DN	ABCC3 CLPX ARHGAP29 OXSR1 HERC1 PDGFC UTRN LIMA1 SHB CLIC3 PON2 ID3 APOE PPP2R2A BCL11B ELL2 EIF4G3	5.15e-05	512	285	17	M4508
Coexpression	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	CENPE MKI67 COL11A1 TNC MSX2 MICAL2 AHNAK2	5.38e-05	89	285	7	M2761
Coexpression	GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP	TPST1 TNC MYRIP ID3 GRIK3 MSX2 RIF1 PPP2R2B BCL11B EIF4G3	6.11e-05	196	285	10	M10014
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	ASH1L CMYA5 RABGAP1L UTRN NIPBL ID3 AKAP13 EIF4G3 KIF13A	6.12e-05	158	285	9	M372
Coexpression	FISCHER_DREAM_TARGETS	AHI1 CAND1 CENPE JADE1 NUP205 FANCA ANLN MKI67 TIMELESS DIAPH3 NIPBL CASP8AP2 WEE1 RBL1 USP28 TNPO2 AHCTF1 HAUS5 WRN FAF1 RIF1 POLR1E EXO1 CKAP2L CEP295	6.43e-05	969	285	25	M149
Coexpression	GENTILE_UV_LOW_DOSE_DN	STK39 UTRN TPST1 SATB2 MICAL2 EIF4G3	6.93e-05	64	285	6	M4594
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	FRS2 SAMD9L AGO4 HERC1 MED12 AGAP3 KRAS TRMO APOE SUSD5	6.93e-05	199	285	10	M9501
Coexpression	GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN	ANLN MKI67 TSC22D3 TNC MSX2 XIRP2 EXO1 CKAP2L	6.94e-05	125	285	8	M8930
Coexpression	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	CEP350 MTUS1 MED23 MBD4 KRAS NDNF COL6A3 MED1 TIAM1 LRBA	7.23e-05	200	285	10	M8032
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	TLR8 DENND5A MBD4 PDGFC NDNF VPS18 RBL1 MFSD9 CKAP2L LRBA	7.23e-05	200	285	10	M8048
Coexpression	GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN	CAND1 TYSND1 MECP2 FANCA EIF4ENIF1 KRAS WEE1 AHCTF1 EXO1 AATF	7.23e-05	200	285	10	M8600
Coexpression	SHEN_SMARCA2_TARGETS_UP	SLK CAND1 ATRX POLR2M UPF3B MECP2 CEP350 ARHGAP29 MBD4 TANK KTN1 PON2 ANP32A SMARCA2 RHOT1	8.03e-05	429	285	15	M29
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	KDM3A SLK AHI1 FRS2 UPF3B ZKSCAN5 BPGM AGO3 MTUS1 NIPBL TANK ZSCAN5A WRN TRMO SORBS1 RHOQ PPP2R2A RESF1 PCNX1 RGS17 ARHGEF3 AHNAK2	1.06e-04	822	285	22	M6782
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1	ABHD17A PALMD THSD1 ITPR3 MALT1 PHLDB1 PTPRB HPCAL1 ARHGAP29 KDR UTRN PON2 ID3 SORBS1 ABLIM1	1.06e-04	440	285	15	M39039
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	ABHD17A SLK LAYN SLCO2B1 PALMD THSD1 ZYX ITPR3 MALT1 PTPRB MTUS1 ARHGAP29 KDR UTRN TSC22D3 MYRIP PON2 ID3 ABLIM1 ELL2 TIAM1 XIRP2 SMARCA2	1.20e-04	888	285	23	M39049
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN	LAYN SLCO2B1 TLR8 TYROBP LPCAT2 MTUS1 PDGFC APOE ARHGEF3	1.40e-04	176	285	9	M6757
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	ABCC3 PDE3A SLK ZYX TYROBP PARP4 BPGM LPCAT2 MTUS1 HPCAL1 ARHGAP29 OXSR1 AMOTL2 PDGFC UTRN SDHA LIMA1 SHROOM3 WEE1 PON2 ID3 CPA3 RHOQ FRMD4A RESF1 LMNA LMO7 AKAP13 KDSR	1.54e-04	1276	285	29	M39173
Coexpression	BENPORATH_NOS_TARGETS	KDM3A JADE1 UBR5 KDR MED12 CACNA2D1 TNC RIF1 RESF1	1.59e-04	179	285	9	M14573
Coexpression	LIU_SOX4_TARGETS_DN	ABHD17A CDK16 TBC1D9B MECP2 ITPR3 SHROOM3 TSC22D3 FAF1 PPP2R2A SMARCA2 ZNF654 RPL13	1.63e-04	310	285	12	M17287
Coexpression	ONKEN_UVEAL_MELANOMA_UP	AHI1 DCAF8 WWC3 TRIO TYROBP UBXN2B UBR5 RABGAP1L KDR DENND5A PLTP SDHA CASP8AP2 RGS20 AKAP13 SPIDR EIF4G3 CSPP1 RHOT1 AHNAK2 PHACTR1	1.67e-04	790	285	21	M12490
Coexpression	CUI_TCF21_TARGETS_2_DN	SLK CTTNBP2 ASH1L FRS2 JADE1 MALT1 PARP4 PTPRB AGO4 MTUS1 RABGAP1L VPS13A ARHGAP29 MED23 UBE2Q2 SHROOM3 PON2 SORBS1 ELL2 TCP11L2 LMO7 LRBA	1.82e-04	854	285	22	M1533
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	ERCC5 CNST SDCCAG8 TENT5C CLPX UBR5 UTRN RIF1 VPS13D	1.95e-04	184	285	9	M9005
Coexpression	ZHU_CMV_8_HR_DN	ERCC5 WEE1 APOE LMNA ANP32A	2.08e-04	50	285	5	M9806
Coexpression	HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS	RYR3 RABGAP1L TBC1D14 CACNA1E ABLIM1 SMARCA2 PCNX1 PHACTR1	2.14e-04	147	285	8	MM414
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL	PRTG CENPE ANLN MKI67 TIMELESS PDGFC SHROOM3 WEE1 LMNB2 LRP2 CKAP2L ZFHX3	2.31e-04	322	285	12	M39060
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	CDK16 AHI1 CENPE JADE1 FANCA ANLN MKI67 TIMELESS DIAPH3 CASP8AP2 WEE1 RBL1 HAUS5 LMNB2 FAF1 RIF1 EXO1 CKAP2L CEP295	2.36e-04	694	285	19	M45767
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	CENPE UBR5 ANLN PLCL2 KTN1 TIAM1 LMO7 PCNX1 CSPP1	2.89e-04	194	285	9	M7467
Coexpression	GSE29618_BCELL_VS_PDC_UP	WWC3 TRIO TENT5C MBD4 TANK TSC22D3 POU2AF1 ABLIM1 RESF1	3.12e-04	196	285	9	M4940
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	AHI1 LRP1B MTUS1 HERC1 TPST1 LIMA1 SHROOM3 ABLIM1 LMNA SMARCA2	3.19e-04	240	285	10	M39236
Coexpression	GHO_ATF5_TARGETS_UP	NEB RBM45 RIF1	3.36e-04	13	285	3	M12008
Coexpression	GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP	MYH6 TENT5C CEP350 PTPRB BPGM TBC1D14 NIPBL ELL2 ANP32A	3.48e-04	199	285	9	M9600
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP	MYH6 CAND1 ZKSCAN5 FANCA HPCAL1 KDR STK39 CCDC167 TIAM1	3.48e-04	199	285	9	M3886
Coexpression	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP	SDCCAG8 TENT5C HERC1 MED23 UBE2Q2 PON2 DAW1 CKAP2L ZNF839	3.48e-04	199	285	9	M4316
Coexpression	KATSANOU_ELAVL1_TARGETS_DN	LAYN FANCA IGSF10 TIMELESS TNPO2 TIAM1 VWA5A SIGLEC11	3.49e-04	158	285	8	MM934
Coexpression	JONES_OVARY_MACROPHAGE	SLCO2B1 PALMD CMYA5 PTPRB ARHGAP29 KDR UTRN PLTP APOE LMNA	3.52e-04	243	285	10	M48355
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	CTTNBP2 ARHGAP29 UTRN SHROOM3 FRMD4A SPIDR	3.56e-04	86	285	6	M39248
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	TRIO CENPE PARP4 NIPBL NPTX1 NLGN4Y RGS20 LMNA MICAL2 AKAP13 AHNAK2	3.61e-04	290	285	11	M13251
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	ATRX MECP2 RABGAP1L MBD4 NIPBL APOE AKAP13 ZFHX3 ARHGEF3	3.61e-04	200	285	9	M8050
Coexpression	GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP	SLCO2B1 TYROBP PARP4 LPCAT2 MBD4 TSC22D3 ANKRD44 RHOQ TCP11L2	3.61e-04	200	285	9	M9737
Coexpression	GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP	ASH1L TENT5C CEP350 UTRN AGAP3 WRN CLASRP SMARCA2 RHOT1	3.61e-04	200	285	9	M9608
Coexpression	GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP	UIMC1 ASH1L UPF3B TBC1D14 TPST1 POU2AF1 RHOQ ELL2 LMO7	3.61e-04	200	285	9	M8550
Coexpression	GSE17721_POLYIC_VS_CPG_24H_BMDC_DN	INTS1 MECP2 MKI67 OXSR1 AHCTF1 PIWIL2 MEPCE PCNX1 KIF13A	3.61e-04	200	285	9	M3954
Coexpression	GSE557_WT_VS_CIITA_KO_DC_DN	PLCL2 TBC1D14 ARHGAP29 KRAS SHB SORBS1 ANKRD44 PPP2R2A ARHGEF3	3.61e-04	200	285	9	M6008
Coexpression	GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	MALT1 VPS13A UTRN NIPBL UBE2Q2 PON2 SORBS1 RGS20 ARHGEF3	3.61e-04	200	285	9	M5089
Coexpression	GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN	ABCC3 CENPE RYR3 SAMD9L LPCAT2 CPS1 FRMD4A CKAP2L AATF	3.61e-04	200	285	9	M6457
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP	PDE3A CNST ZNF423 TENT5C OTOP3 ZKSCAN5 PTPRB ZDBF2 CCDC167	3.61e-04	200	285	9	M7986
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	ABHD17A CDK16 TBC1D9B SAMD9L AGO4 LPCAT2 MBD4 RIF1 KDSR	3.61e-04	200	285	9	M6653
Coexpression	GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	KDM3A UPF3B MALT1 HPCAL1 OXSR1 DENND5A USP28 ELL2 ZNF654	3.61e-04	200	285	9	M5338
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP	ATRX TRIO CENPE PLCL2 KDR TIMELESS STK39 PPP2R2A PCNX1	3.61e-04	200	285	9	M4048
Coexpression	GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP	TRIO CLPX ZFR2 SDHA KTN1 SHB TIAM1 SPIDR PHACTR1	3.61e-04	200	285	9	M5220
Coexpression	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	TBC1D9B TRIO LRP1B PHF2 PLCL2 KDR SNX12 DOT1L AHNAK2	3.61e-04	200	285	9	M6583
Coexpression	GSE17721_0.5H_VS_4H_CPG_BMDC_DN	MKI67 DENND5A SATB2 TANK RBL1 PPP2R2A ELL2 ARHGEF3 IKBKB	3.61e-04	200	285	9	M4125
Coexpression	GSE3982_DC_VS_NKCELL_UP	TRIO CENPE SLCO2B1 NLGN3 HPCAL1 PDGFC GPER1 SHB PCDHA10	3.61e-04	200	285	9	M5478
Coexpression	GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN	LAYN MRPL37 STAMBPL1 OXSR1 SNX12 PLTP KTN1 FAF1 EXO1	3.61e-04	200	285	9	M4178
Coexpression	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	KDM3A CLPX STRADB RABGAP1L DENND5A UTRN FAF1 AKAP13 ARHGEF3	3.61e-04	200	285	9	M6943
Coexpression	GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP	SLK CENPE INTS1 TENT5C GFPT2 KRAS AHCTF1 BCL11B TIAM1	3.61e-04	200	285	9	M5617
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	ATRX BSPRY INTS1 POLR2M RYR3 NCBP3 CEP350 MALT1 UBR5 RABGAP1L PLCL2 TIMELESS OXSR1 MBD4 NIPBL TANK TSC22D3 KTN1 WDR70 CLIC3 FAF1 RHOQ LRPPRC LRBA IKBKB RHOT1 RPL13	3.72e-04	1215	285	27	M41122
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN	VAPA CDK16 ZNF134 ETV3 TENT5C SLC25A30 POLR2M JADE1 THSD1 MED23 KRAS VPS18 TRIM58 AHCTF1 ID3 PPP2R2A ELL2 TCP11L2 MEPCE PCNX1 PHACTR1	4.03e-04	844	285	21	M41129
Coexpression	TOOKER_GEMCITABINE_RESISTANCE_DN	MALT1 HPCAL1 ARHGAP29 STK39 MBD4 PDGFC TIAM1	4.05e-04	123	285	7	M18806
Coexpression	JONES_OVARY_ENDOTHELIAL	SLCO2B1 PALMD PTPRB ARHGAP29 KDR UTRN ABLIM1 LMNA	4.13e-04	162	285	8	M48350
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	KDM3A ABCC3 CMYA5 ZYX PHLDB1 LPCAT2 LNX1 LIMA1 TSC22D3 ID3 MSX2 TCP11L2 LMO7 ZNF654 AHNAK2	4.53e-04	504	285	15	M2157
Coexpression	OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	ZNF134 PUS3 ZKSCAN5 PCNX2 SPTBN5 SCNM1 BPGM EIF4ENIF1 ARHGAP29 AHCTF1 FRMD4A AATF	4.78e-04	349	285	12	M283
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGBP	PRTG CENPE KIF2B ANLN MKI67 TIMELESS SHROOM3 WEE1 LMNB2 LRP2 CKAP2L	4.80e-04	300	285	11	M39059
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	ASH1L TENT5C MALT1 STK39 NIPBL KTN1 VWA5A MPHOSPH10	4.86e-04	166	285	8	M8129
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	HPCAL1 RABGAP1L ARHGAP29 PPP1R35 PLTP COL6A3 TSC22D3 RBL1 WDPCP VWA5A ANP32A SPIDR ANP32D	5.13e-04	403	285	13	MM1029
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CENPE JADE1 NEB CEP350 PHF2 PPP1R2B BPGM MTUS1 UBR5 NEGR1 STARD9 VPS13A CASP8AP2 CACNA2D1 KTN1 ZDBF2 CLIP3 RIF1 RGS20 ANP32A EXO1 AKAP13 RGS17 MPHOSPH10 PHACTR1	2.57e-06	654	283	25	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	PUS3 ATRX TRIO ASH1L TENT5C NCBP3 AGO3 STARD9 KDR STK39 HERC1 UTRN PLTP NRIP2 SDK2 COL11A1 RBM45 APOE CLIP3 RIF1 VPS13D RESF1 VWA5A ASXL3 SMARCA2 CEP295 CSPP1 AHNAK2	2.72e-06	790	283	28	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	AHI1 ATRX CENPE UPF3B MKI67 NIPBL MAP3K19 CASP8AP2 CACNA2D1 CLIP3 RIF1 EXO1 CKAP2L CEP295 MPHOSPH10 LRBA	4.77e-06	311	283	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	PRTG CENPE SDCCAG8 JADE1 FANCA CEP350 PHF2 TYROBP PPP1R2B MTUS1 UBR5 ZFR2 RABGAP1L VPS13A PDGFC CASP8AP2 COL6A3 CACNA2D1 TNC KTN1 ZDBF2 CLIP3 RIF1 ANP32A EXO1 LRP2 RGS17 MPHOSPH10 LRBA CDH7 PHACTR1	8.38e-06	983	283	31	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	UIMC1 PDE3A ATRX CENPE ASH1L MECP2 ZKSCAN5 IFT43 FANCA CRACD TBC1D14 MKI67 MBD4 UTRN NIPBL SDHA COL6A3 LIMA1 TNC WDPCP ABLIM1 BCL11B ELL2 TIAM1 ASXL3 CKAP2L ZFHX3 LRBA IKBKB KIF13A RPL13	8.73e-06	985	283	31	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX CENPE PPP1R2B UBR5 NIPBL MAP3K19 CASP8AP2 KTN1 ZDBF2 RIF1 CEP295 MPHOSPH10	1.09e-05	192	283	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	CTTNBP2 ETV3 TOGARAM1 MECP2 NLGN3 AGO4 STAMBPL1 TERB2 NDNF WEE1 TNC CPA3 ANKRD44 RIF1 ELL2 LMO7 ZFHX3 IKBKB KDSR	3.69e-05	492	283	19	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	ATRX CENPE ASH1L NEB PCNX2 BPGM AGO3 MTUS1 ARHGAP29 HERC1 TERB2 NRIP2 TDRD5 RBM45 MYRIP PIWIL2 RIF1 ABLIM1 ELL2 RESF1 LMO7 PHACTR3 WEE2 CEP295 CSPP1	4.09e-05	770	283	25	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	TOGARAM1 CEP350 SAMD9L VPS13A STAMBPL1 HERC1 UTRN MED12 USP28 ANKRD44 RIF1 ABLIM1 LRPPRC BCL11B TCP11L2	4.93e-05	336	283	15	GSM538413_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	AHI1 CENPE TENT5C FANCA IGSF10 TYROBP LPCAT2 NEGR1 ZFR2 MKI67 PDGFC MAP3K19 CASP8AP2 COL6A3 CACNA2D1 SATB2 TNC ZDBF2 ANKRD44 BCL11B ELL2 LMO7 VWA5A ASXL3 CKAP2L WEE2 LRBA CDH7 PHACTR1	5.09e-05	978	283	29	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	SLK ATRX CENPE ZKSCAN5 FANCA MKI67 NIPBL MAP3K19 LIMA1 SATB2 CLIP3 RIF1 BCL11B ANP32A CKAP2L CEP295 LRBA	7.55e-05	432	283	17	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	PRTG TENT5C FANCA IGSF10 TYROBP PPP1R2B LPCAT2 NEGR1 ZFR2 RABGAP1L PDGFC COL6A3 CACNA2D1 SHROOM3 TNC KTN1 SHB ANKRD44 MSX2 BCL11B ELL2 LMO7 VWA5A LRP2 RGS17 ZFHX3 LRBA PHACTR1	1.15e-04	973	283	28	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	KDM3A PRTG TBC1D9B AHI1 ZNF423 LRP1B C17orf75 NLGN4X UBR5 ARHGAP29 TIMELESS MED12 TCTN1 CACNA2D1 SDK2 USP28 PPFIA4 HAUS5 ID3 ZDBF2 CPS1 CCDC57 PRR7 MSX2 FRMD4A CLIP3 LRPPRC TIAM1 LRP2 DOT1L KIF13A ZNF654 RHOT1	1.33e-04	1245	283	33	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	AHI1 ATRX CENPE ASH1L UPF3B MECP2 CRACD PPP1R2B C17orf75 UBR5 VPS13A MKI67 NIPBL MAP3K19 CASP8AP2 CACNA2D1 KTN1 ZDBF2 WDPCP CLIP3 RIF1 EXO1 CEP295 MPHOSPH10 IKBKB	1.37e-04	831	283	25	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	ETV3 NLGN3 AGO4 STAMBPL1 NDNF TNC CPA3 ANKRD44 RIF1 BCL11B LMO7 ZFHX3	1.37e-04	249	283	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	PUS3 ATRX ASH1L NCBP3 STARD9 HERC1 UTRN PLTP NRIP2 NDNF COL11A1 RBM45 RIF1 RESF1 ASXL3 CEP295	1.47e-04	413	283	16	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000	ABCC3 PRTG AHI1 CAND1 ATRX SLCO2B1 RYR3 TYROBP PTPRB AGO4 LPCAT2 NEGR1 NRIP2 TDRD5 NDNF LCA5 CACNA2D1 SATB2 NPTX1 RBL1 BRCC3 STMND1 ZDBF2 ASXL3 ARHGEF3	1.50e-04	836	283	25	gudmap_developingKidney_e15.5_Podocyte cells_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2	TENT5C FANCA TYROBP COL6A3 CACNA2D1 SATB2 SDK2 ANKRD44 VWA5A	1.62e-04	147	283	9	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	UIMC1 PDE3A IFT43 FANCA UTRN COL6A3 LIMA1 ABLIM1 ELL2 ASXL3 ZFHX3	1.68e-04	217	283	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	UIMC1 PDE3A ATRX CENPE TENT5C FANCA IGSF10 TYROBP STARD9 MKI67 NIPBL COL6A3 CACNA2D1 LIMA1 SATB2 SDK2 ANKRD44 CLIP3 VWA5A SUSD5 ASXL3 CKAP2L AKAP13	1.72e-04	744	283	23	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500	ATRX NEB ARHGAP29 HERC1 TERB2 TDRD5 RBM45 MYRIP PIWIL2 RIF1 ABLIM1 ELL2 RESF1 LMO7 WEE2	1.87e-04	379	283	15	gudmap_developingGonad_P2_ovary_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	PUS3 ATRX TRIO ASH1L TENT5C AGO3 STARD9 KDR STK39 HERC1 UTRN PLTP NRIP2 COL11A1 RBM45 APOE RIF1 RESF1 LMNA ASXL3 SMARCA2 CEP295 CSPP1 AHNAK2	1.91e-04	799	283	24	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	PUS3 ATRX TRIO ASH1L NCBP3 AGO3 STARD9 KDR HERC1 UTRN PLTP NRIP2 NDNF COL11A1 RBM45 APOE CLIP3 RIF1 RESF1 ASXL3 SMARCA2 ZFHX3 CEP295 CSPP1	1.98e-04	801	283	24	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	AHI1 ATRX CENPE SLCO2B1 ZNF423 UPF3B CRACD UBXN2B VPS13A MKI67 HERC1 NIPBL LCA5 CASP8AP2 RBL1 USP28 MYRIP ZDBF2 WDPCP FRMD4A CLIP3 RIF1 ANP32A EXO1 CKAP2L CEP295 MPHOSPH10 CSPP1 PHACTR1	2.04e-04	1060	283	29	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000	ABCC3 PRTG AHI1 CAND1 CENPE SLCO2B1 THSD1 PTPRB NEGR1 TIMELESS NRIP2 TRMT9B NDNF CACNA2D1 SATB2 NPTX1 SDK2 RBM45 STMND1 ZDBF2 LMNB2 ASXL3 EXO1 CEP295 EIF4G3	2.12e-04	855	283	25	gudmap_developingKidney_e13.5_podocyte cells_1000
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500	PRTG AHI1 CAND1 SLCO2B1 THSD1 PTPRB NEGR1 NRIP2 NDNF SATB2 NPTX1 RBM45 ZDBF2 ASXL3 EXO1 CEP295	2.37e-04	431	283	16	gudmap_developingKidney_e13.5_podocyte cells_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	KDM3A PDE3A CENPE CEP350 ANLN ARHGAP29 KDR STK39 DIAPH3 PDGFC CASP8AP2 COL6A3 CACNA2D1 SHROOM3 WEE1 TNC RBL1 ZDBF2 PPP4R4 CLIP3 MICAL2 ASXL3 EXO1 SPIDR	3.16e-04	827	283	24	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	SLK ATRX CENPE POLR2M ZKSCAN5 PPP1R2B MKI67 MED23 NIPBL UBE2Q2 MAP3K19 KRAS CACNA2D1 WEE1 KTN1 CLIP3 RIF1 ANP32A CEP295 CSPP1	3.19e-04	629	283	20	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_500	PRTG NPTX1 RBM45 ZDBF2 ASXL3 EXO1 CEP295	3.41e-04	98	283	7	gudmap_developingKidney_e13.5_podocyte cells_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000	TRIO NDNF RBM45 CLIP3 ASXL3 ZFHX3 CSPP1	3.63e-04	99	283	7	gudmap_developingGonad_e14.5_ epididymis_1000_k1
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	PDE3A TENT5C FANCA IGSF10 TYROBP AGO3 STARD9 COL6A3 CACNA2D1 SATB2 SDK2 ANKRD44 RHOQ FRMD4A CLIP3 VPS13D BCL11B LMNA VWA5A SUSD5 ASXL3 AKAP13	3.64e-04	734	283	22	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1	ATRX CENPE TENT5C NIPBL CACNA2D1 SATB2 SDK2 CPA3 BCL11B	4.00e-04	166	283	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1
CoexpressionAtlas	CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2	TENT5C SAMD9L ARHGAP29 STK39 STAMBPL1 UTRN PDE11A USP28 RIF1 BCL11B ZNF654 RPL13	4.02e-04	280	283	12	GSM404003_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2	PDE3A TENT5C TYROBP COL6A3 TSC22D3 ANKRD44 VPS13D LMNA	4.41e-04	134	283	8	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500	ABCC3 PRTG AHI1 CAND1 SLCO2B1 RYR3 PTPRB NEGR1 NRIP2 NDNF CACNA2D1 SATB2 RBL1 STMND1 ARHGEF3	4.89e-04	415	283	15	gudmap_developingKidney_e15.5_Podocyte cells_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3	TENT5C FANCA IGSF10 TYROBP ZFR2 COL6A3 CACNA2D1 TNC ANKRD44 BCL11B VWA5A	5.42e-04	249	283	11	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX TRIO SLCO2B1 ASH1L PALMD PTPRB AGO4 UBR5 ARHGAP29 KDR UTRN NIPBL KTN1 RESF1	6.03e-11	200	289	14	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1B ARHGAP29 STK39 DIAPH3 LNX1 TRMT9B TPST1 SHROOM3 WEE1 NLGN4Y PON2 ABLIM1 PHACTR1	3.90e-10	190	289	13	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1B ARHGAP29 STK39 DIAPH3 LNX1 TRMT9B TPST1 SHROOM3 WEE1 NLGN4Y PON2 ABLIM1 PHACTR1	3.90e-10	190	289	13	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 STK39 DIAPH3 LNX1 TRMT9B TPST1 WEE1 NLGN4Y PON2 LMO7 PHACTR3 PHACTR1	4.16e-10	191	289	13	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 STK39 DIAPH3 LNX1 TRMT9B TPST1 WEE1 NLGN4Y PON2 LMO7 PHACTR3 PHACTR1	4.16e-10	191	289	13	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	ATRX SLC25A30 JADE1 CEP350 MTUS1 UTRN NIPBL LIMA1 SHROOM3 KTN1 RHOQ LMO7 SMARCA2	6.90e-10	199	289	13	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	PDE3A PALMD CMYA5 RABGAP1L MYO18B CACNA2D1 SORBS1 ABLIM1 XIRP2 LMO7 AKAP13 PHACTR1	3.21e-09	184	289	12	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 NEGR1 VPS13A LCA5 CACNA2D1 SATB2 NPTX1 LMO7 MICAL2 ASXL3 ARHGEF3 PHACTR1	3.63e-09	186	289	12	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPATA18 IGSF10 TCTN1 MAP3K19 TRMT9B TNC POU2AF1 CFAP43 WDPCP CSPP1 AHNAK2 DNAH11	5.50e-09	193	289	12	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MYH6 PDE3A CMYA5 ALPK3 MYO18B CACNA2D1 SORBS1 WDPCP ABLIM1 XIRP2 LMO7 PHACTR1	5.50e-09	193	289	12	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 ARHGAP29 DIAPH3 TRMT9B TPST1 WEE1 PON2 ABLIM1 LMO7 PHACTR3 PHACTR1	5.50e-09	193	289	12	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 ARHGAP29 DIAPH3 TRMT9B TPST1 WEE1 PON2 ABLIM1 LMO7 PHACTR3 PHACTR1	5.50e-09	193	289	12	80e058c224749b5fe0ba3e944b48317c2371cb63
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 ARHGAP29 DIAPH3 TRMT9B TPST1 WEE1 PON2 ABLIM1 LMO7 PHACTR3 PHACTR1	5.50e-09	193	289	12	b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ASH1L SAMD9L PTPRB KDR UTRN NIPBL COL11A1 TSC22D3 WEE1 SORBS1 LMO7	5.83e-09	194	289	12	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLK PALMD THSD1 PTPRB ARHGAP29 KDR PLTP ID3 FRMD4A ABLIM1 ANP32A SMARCA2	5.83e-09	194	289	12	1b382508453c5b08fb617f626b230adf3b6cff99
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLK PALMD THSD1 PTPRB ARHGAP29 KDR PLTP ID3 FRMD4A ABLIM1 ANP32A SMARCA2	6.18e-09	195	289	12	cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 PALMD NEGR1 PDGFC CACNA1E NPTX1 SHB PPP2R2B BCL11B LMO7 PHACTR3 CDH7	7.34e-09	198	289	12	d81f35c0066558ff96dd06f58fca72cd82e681e8
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO UBR5 RABGAP1L STK39 HERC1 UTRN WDR70 WDPCP FAF1 SPIDR LRBA EIF4G3	7.76e-09	199	289	12	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPE TENT5C ANLN MKI67 DIAPH3 WEE1 CLIC3 BCL11B TRBV7-4 HEATR9 CKAP2L	2.02e-08	174	289	11	b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPE TENT5C ANLN MKI67 DIAPH3 WEE1 CLIC3 BCL11B TRBV7-4 HEATR9 CKAP2L	2.02e-08	174	289	11	94575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPE TENT5C ANLN MKI67 DIAPH3 WEE1 CLIC3 BCL11B TRBV7-4 HEATR9 CKAP2L	2.02e-08	174	289	11	40c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PALMD ZYX RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	2.27e-08	176	289	11	e4b21fd6a5e0c5950f27c3e1868318e48330ae5e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ASH1L PALMD SAMD9L PTPRB ARHGAP29 KDR UTRN CASP8AP2 KTN1 LMO7	2.56e-08	178	289	11	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 LRP1B ARHGAP29 PDGFC TRMT9B NPTX1 COL11A1 TNC GRIK3 CDH7 PHACTR1	2.71e-08	179	289	11	b35a7f8115c997c390201da01d7cb10b10769aec
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB LRP1B RYR3 COL11A1 GRIK3 CPS1 XIRP2 ASXL3 PHACTR3 LRP2 DNAH11	3.60e-08	184	289	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TRIO LRP1B TNC SORBS1 ANKRD44 BCL11B MICAL2 PHACTR3 AKAP13 ARHGEF3	3.60e-08	184	289	11	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB LRP1B RYR3 COL11A1 GRIK3 CPS1 XIRP2 ASXL3 PHACTR3 LRP2 DNAH11	3.60e-08	184	289	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB LRP1B RYR3 COL11A1 GRIK3 CPS1 XIRP2 ASXL3 PHACTR3 LRP2 DNAH11	3.60e-08	184	289	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 LRP1B ARHGAP29 STAMBPL1 TRMT9B NPTX1 COL11A1 TNC GRIK3 CDH7 PHACTR1	3.60e-08	184	289	11	9cc5c588f7c6631b3fb8a522214a09ca32947e72
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 NEGR1 VPS13A LCA5 CACNA2D1 SATB2 NPTX1 LMO7 MICAL2 CDH12 PHACTR1	5.00e-08	190	289	11	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1B ARHGAP29 DIAPH3 LNX1 TRMT9B TPST1 WEE1 NLGN4Y PON2 ABLIM1 PHACTR1	5.27e-08	191	289	11	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TRIO ARHGAP29 DIAPH3 LNX1 TRMT9B TPST1 NLGN4Y PON2 ABLIM1 ARHGEF3	5.27e-08	191	289	11	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MYH6 PDE3A CMYA5 RABGAP1L PLCL2 MYO18B SORBS1 ABLIM1 LMO7 AKAP13 PHACTR1	5.27e-08	191	289	11	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TRIO ARHGAP29 DIAPH3 LNX1 TRMT9B TPST1 NLGN4Y PON2 ABLIM1 ARHGEF3	5.27e-08	191	289	11	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRIO RABGAP1L DENND5A UTRN FAF1 ELL2 PCNX1 AKAP13 SPIDR LRBA EIF4G3	5.86e-08	193	289	11	779276e775cb2492e8dd36436295a536084a6415
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYH6 PDE3A CMYA5 ALPK3 MYO18B SORBS1 ABLIM1 XIRP2 LMO7 AKAP13 PHACTR1	6.51e-08	195	289	11	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	VPS13A STAMBPL1 HERC1 MED23 UTRN CPA3 ZDBF2 ANKRD44 BCL11B SMARCA2 LRBA	7.22e-08	197	289	11	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PALMD LRP1B RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	8.42e-08	200	289	11	e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PALMD LRP1B RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	8.42e-08	200	289	11	1ce9599cc9d8158e8842ca56f35fa7809c234849
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PALMD LRP1B RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	8.42e-08	200	289	11	7b845aabfbdfe893acc9334a5707833761bed60b
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PALMD LRP1B RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	8.42e-08	200	289	11	0638273fc0910f47fe7a0b6d9a8639b0e9976d13
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRTG NEB LRP1B PDE11A TDRD5 COL11A1 CPS1 PPP2R2B SUSD5 CDH12	1.12e-07	162	289	10	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-lung-MAST\|lung / Disease (COVID-19 only), tissue and cell type	PDE3A CTTNBP2 RYR3 PARP4 LPCAT2 CACNA2D1 CPA3 ANKRD44 VWA5A RGS17	1.76e-07	170	289	10	e90f18e5462381b38e918442b38b1c8105291908
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE TRPC4 FANCA CRACD ANLN MKI67 DIAPH3 COL6A3 MICAL2 CKAP2L	1.86e-07	171	289	10	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE TRPC4 FANCA CRACD ANLN MKI67 DIAPH3 COL6A3 MICAL2 CKAP2L	1.86e-07	171	289	10	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPATA18 IGSF10 NLGN4X ANLN MKI67 AMOTL2 SHROOM3 TNC CPS1 CKAP2L	2.30e-07	175	289	10	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PALMD RYR3 TRMT9B SHROOM3 NPTX1 SDK2 SHB GRIK3 BCL11B ZFHX3	2.30e-07	175	289	10	90e29945aa861082c94bb4f331161adc3a6ef899
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPATA18 IGSF10 NLGN4X ANLN MKI67 AMOTL2 SHROOM3 TNC CPS1 CKAP2L	2.30e-07	175	289	10	8a3abf40146ae3459d97cdf865c1c8f6b92ac639
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPATA18 IGSF10 NLGN4X ANLN MKI67 AMOTL2 SHROOM3 TNC CPS1 CKAP2L	2.30e-07	175	289	10	a8400e7e47379901dcab5f2e364c3ff17765b4b9
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPATA18 IGSF10 NLGN4X ANLN MKI67 AMOTL2 SHROOM3 TNC CPS1 CKAP2L	2.30e-07	175	289	10	378d2b79edac91fc74eee0fb42bb29dd9b07c36f
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 PDE3A ATRX CMYA5 TLR8 CEP350 IGSF10 KTN1 APOE XIRP2	2.43e-07	176	289	10	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR3 TRMT9B NPTX1 SDK2 COL11A1 SHB GRIK3 BCL11B LMO7 ZFHX3	2.56e-07	177	289	10	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP29 STAMBPL1 PDGFC UTRN SATB2 NPTX1 COL11A1 SHB GRIK3 CDH7	2.84e-07	179	289	10	53e700494d251ec5649b2dea5fc7d5aeeeed572b
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PALMD RYR3 TRMT9B NPTX1 SDK2 COL11A1 SHB GRIK3 BCL11B ZFHX3	2.84e-07	179	289	10	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	ABCC3 CTTNBP2 SLCO2B1 LPCAT2 ALPK3 PDGFC PLTP APOE FRMD4A SIGLEC11	2.99e-07	180	289	10	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZYX RYR3 TRMT9B NPTX1 SDK2 COL11A1 SHB GRIK3 BCL11B LMO7	3.15e-07	181	289	10	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX TLR8 CEP350 SAMD9L STAMBPL1 NIPBL KTN1 ID3 POU2AF1 EIF4G3	3.31e-07	182	289	10	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PALMD RYR3 TRMT9B NPTX1 SDK2 COL11A1 SHB GRIK3 BCL11B ZFHX3	3.48e-07	183	289	10	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A LRP1B NLGN4X STK39 STAMBPL1 LNX1 CPS1 ABLIM1 PHACTR3 PHACTR1	3.66e-07	184	289	10	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 PDE3A PALMD CMYA5 ALPK3 MYO18B CACNA2D1 SORBS1 ABLIM1 XIRP2	3.85e-07	185	289	10	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	PDE3A PALMD CMYA5 RABGAP1L MYO18B SORBS1 ABLIM1 XIRP2 LMO7 PHACTR1	3.85e-07	185	289	10	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX TLR8 CEP350 SAMD9L STAMBPL1 NIPBL KTN1 ID3 POU2AF1 EIF4G3	3.85e-07	185	289	10	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PALMD CEP350 SAMD9L PTPRB ARHGAP29 KDR UTRN KTN1 LMO7	4.05e-07	186	289	10	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE FANCA NEGR1 ANLN MKI67 DIAPH3 COL6A3 TNC EXO1 CKAP2L	4.25e-07	187	289	10	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	PDE3A CTTNBP2 PTPRB ARHGAP29 CACNA2D1 MYRIP CPA3 MSX2 VWA5A AHNAK2	4.25e-07	187	289	10	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE FANCA NEGR1 ANLN MKI67 DIAPH3 COL6A3 TNC EXO1 CKAP2L	4.25e-07	187	289	10	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	PDE3A CTTNBP2 PTPRB ARHGAP29 CACNA2D1 MYRIP CPA3 MSX2 VWA5A AHNAK2	4.25e-07	187	289	10	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	ASK452-Immune-Mast_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	PDE3A CTTNBP2 LPCAT2 TSC22D3 CPA3 SORBS1 ELL2 LMNA VWA5A AKAP13	4.47e-07	188	289	10	840215e16cff90f821f776186284eafcf2350690
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	PDE3A CMYA5 ALPK3 MYO18B SORBS1 ABLIM1 ELL2 XIRP2 AKAP13 PHACTR1	4.69e-07	189	289	10	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PDE3A CMYA5 PLCL2 MYO18B SORBS1 ABLIM1 XIRP2 LMO7 AKAP13 PHACTR1	4.69e-07	189	289	10	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1B RYR3 ITPR3 NLGN4X STK39 LNX1 WEE1 LMO7 PHACTR3 PHACTR1	4.69e-07	189	289	10	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 NEGR1 VPS13A LCA5 CACNA2D1 SATB2 NPTX1 MICAL2 CDH12 PHACTR1	4.69e-07	189	289	10	a75226616340045b581d08429d2e123e041dee55
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	TRPC4 RYR3 STAMBPL1 TRMT9B SHROOM3 TNC SORBS1 PPP2R2B MICAL2 KIF13A	4.69e-07	189	289	10	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 ARHGAP29 DIAPH3 TRMT9B SATB2 PON2 LMO7 PHACTR3 PHACTR1	4.92e-07	190	289	10	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	PDE3A CMYA5 ALPK3 MYO18B SORBS1 ABLIM1 ELL2 XIRP2 AKAP13 PHACTR1	4.92e-07	190	289	10	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PDE3A CMYA5 RABGAP1L PLCL2 MYO18B SORBS1 ABLIM1 LMO7 AKAP13 PHACTR1	4.92e-07	190	289	10	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 PDE3A PALMD CMYA5 NEGR1 MYO18B CACNA2D1 SORBS1 ABLIM1 XIRP2	4.92e-07	190	289	10	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL4 NEGR1 VPS13A LCA5 CACNA2D1 SATB2 NPTX1 MICAL2 CDH12 PHACTR1	4.92e-07	190	289	10	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MYH6 PDE3A CMYA5 PLCL2 MYO18B SORBS1 ABLIM1 LMO7 AKAP13 PHACTR1	4.92e-07	190	289	10	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PHLDB1 NLGN4X NEGR1 GFPT2 COL6A3 TSC22D3 NLGN4Y APOE ANKRD44 ZFHX3	5.16e-07	191	289	10	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	MYH6 CMYA5 RABGAP1L MYO18B CACNA1E USP28 SORBS1 ABLIM1 LMO7 PHACTR1	5.16e-07	191	289	10	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FSTL4 PHLDB1 STARD9 ARHGAP29 KDR ID3 SORBS1 ABLIM1 ARHGEF3 CSPP1	5.16e-07	191	289	10	f229abf69a1217194f74b0502486907e07dba989
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAYN NEB RYR3 HPCAL1 PDGFC SATB2 GPER1 RIN1 AKAP13	5.52e-07	148	289	9	fc80c02b51cf55a04ce550838ee2f41d8f656f41
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	PHLDB1 NLGN4X LPCAT2 NEGR1 GFPT2 COL6A3 TANK TSC22D3 ANKRD44 ZFHX3	5.68e-07	193	289	10	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	JADE1 PHLDB1 NLGN4X LPCAT2 NEGR1 GFPT2 COL6A3 TANK ANKRD44 ZFHX3	5.96e-07	194	289	10	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ITPR3 PARP4 ARHGAP29 DIAPH3 TPST1 SATB2 LMO7 PHACTR3 PHACTR1	5.96e-07	194	289	10	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO LRP1B DLGAP3 ARHGAP29 STK39 LIMA1 SHROOM3 ABLIM1 AKAP13 DOT1L	5.96e-07	194	289	10	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	PHLDB1 NLGN4X LPCAT2 NEGR1 GFPT2 COL6A3 TSC22D3 APOE ANKRD44 ZFHX3	5.96e-07	194	289	10	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO LRP1B DLGAP3 ARHGAP29 STK39 LIMA1 SHROOM3 ABLIM1 AKAP13 DOT1L	5.96e-07	194	289	10	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TRIO ITPR3 ARHGAP29 DIAPH3 TRMT9B TPST1 NLGN4Y PHACTR3 PHACTR1	6.24e-07	195	289	10	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TRIO ITPR3 ARHGAP29 DIAPH3 TRMT9B TPST1 NLGN4Y PHACTR3 PHACTR1	6.24e-07	195	289	10	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLK CENPE PALMD THSD1 PTPRB ANLN MKI67 ARHGAP29 KDR CKAP2L	6.24e-07	195	289	10	eca24039bde02f4677f1f89a373f501c649ec2a5
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	CENPE ANLN MKI67 TIMELESS DIAPH3 WEE1 MYRIP CCDC167 EXO1 CKAP2L	6.85e-07	197	289	10	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A TRPC4 NEGR1 GFPT2 UTRN COL6A3 TNC SORBS1 LMNA MICAL2	6.85e-07	197	289	10	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPE TENT5C SRPRA MKI67 TIMELESS DIAPH3 POU2AF1 ELL2 EXO1 CKAP2L	7.18e-07	198	289	10	2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	AMOTL2 NDNF TPST1 COL6A3 SATB2 COL11A1 TNC ID3 LMO7 SUSD5	7.18e-07	198	289	10	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	AMOTL2 NDNF TPST1 COL6A3 SATB2 COL11A1 TNC ID3 LMO7 SUSD5	7.18e-07	198	289	10	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	ATRX SLC25A30 NIPBL LIMA1 KTN1 RHOQ SMARCA2 EIF4G3 KDSR AHNAK2	7.51e-07	199	289	10	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(7)_Mast_cell\|World / shred on Cell_type and subtype	PDE3A CTTNBP2 TYROBP LPCAT2 CACNA2D1 CPA3 APOE MSX2 LMNA VWA5A	7.51e-07	199	289	10	c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-dn_T\|Int-URO / Disease, condition lineage and cell class	MRPL37 UBR5 STK39 LNX1 LIMA1 TRIM58 POU2AF1 BCL11B TBCK LRBA	7.87e-07	200	289	10	020439d9e70fff7246650ab0e9105236688c3ec3
Drug	N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA	ZNF134 AHI1 MALT1 AGO3 VPS13A GFPT2 GPER1 TSC22D3 WEE1 MED1 PRR7 LMNA TIAM1 ZFHX3	2.02e-07	198	283	14	842_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A	CDK16 ERCC4 DCAF8 MALT1 TCTN1 TPST1 RBL1 HAUS5 MFSD9 TRMO ZNF839 RHOT1 RPL13	1.21e-06	197	283	13	6226_DN
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A	TBC1D9B NEB BPGM VPS13A TIMELESS RBL1 HAUS5 MFSD9 PPP2R2B BCL11B PCNX1 ZNF839	6.07e-06	194	283	12	5674_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	ATRX NEB C17orf75 MTUS1 TRIM58 HAUS5 TRMO LMO7 VWA5A SMARCA2 PCNX1 CSPP1	6.40e-06	195	283	12	6648_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	ZNF134 TPST1 WEE1 TNPO2 SHB PRR7 PPP2R2B BRF1 PCNX1 ZNF839 KIF13A ZNF654	6.74e-06	196	283	12	4775_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A	ERCC4 SRPRA UTRN TCTN1 MFSD9 APOE RIN1 VPS13D LRP2 AKAP13 ARHGEF3 IKBKB	7.10e-06	197	283	12	1282_UP
Drug	9,10-Dimethyl-1,2-benzanthracene	CDK16 ABCC3 SLK NEB IGSF10 MALT1 VPS13A MKI67 KDR SNX12 CACNA2D1 NPTX1 COL11A1 TNC PPFIA4 CLIC3 PON2 ID3 APOE FAF1 ABLIM1 PPP2R2A PPP2R2B BCL11B RGS20 LMNA TCP11L2 MEPCE LTV1 IKBKB RPL4	7.29e-06	1046	283	31	ctd:D015127
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A	ABCC3 MTUS1 UBR5 MKI67 GFPT2 NIPBL TCTN1 ZSCAN5A SHB MED1 SPIDR LRBA	7.87e-06	199	283	12	122_DN
Drug	Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A	AHI1 MALT1 RABGAP1L TIMELESS TCTN1 TPST1 HAUS5 SHB BCL11B LMNA VWA5A PCNX1	7.87e-06	199	283	12	6495_DN
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ZNF423 TENT5C CEP350 PLCL2 LIMA1 GPER1 ID3 PPP4R4 RGS20 VWA5A AHNAK2	2.04e-05	184	283	11	3244_UP
Drug	fluvastatin	ERCC5 SLCO2B1 RABGAP1L ARHGAP29 MED23 APOE LMNA ARHGEF3	2.46e-05	95	283	8	ctd:C065180
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	ABCC3 FRS2 TENT5C ZYX CEP350 PCNX2 BPGM NIPBL MED12 SHB ZFHX3	3.33e-05	194	283	11	2824_DN
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A	ABCC3 DCAF8 PALMD NCBP3 UTRN PRR7 RIF1 TIAM1 SMARCA2 ZFHX3 IKBKB	3.33e-05	194	283	11	1827_UP
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	ERCC4 AGO4 MTUS1 RABGAP1L SATB2 TSC22D3 PPFIA4 MFSD9 RIF1 VPS13D ZNF839	3.65e-05	196	283	11	4629_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	ZNF134 MKI67 GPER1 TNC RBL1 SHB VPS13D EXO1 AKAP13 ZNF839 CSPP1	3.65e-05	196	283	11	1807_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TRIO TENT5C RABGAP1L VPS13A NPTX1 MFSD9 VPS13D BCL11B SMARCA2 PCNX1 KIF13A	3.65e-05	196	283	11	3342_DN
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	TBC1D9B AHI1 ASH1L THSD1 RABGAP1L KRAS TANK TNC TRMO ZNF839 CSPP1	3.65e-05	196	283	11	5081_DN
Drug	CAY10397; Up 200; 10uM; PC3; HT_HG-U133A	ABCC3 PHF2 KRAS GPER1 MFSD9 TRMO SORBS1 MED1 LMNA EIF4G3 CSPP1	3.65e-05	196	283	11	7071_UP
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	MECP2 PLTP TANK RBL1 HAUS5 SHB FRMD4A BCL11B LMNA TIAM1 PCNX1	3.65e-05	196	283	11	7408_UP
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	AHI1 ERCC4 CEP350 GFPT2 UTRN KRAS CPS1 PRR7 MSX2 PCNX1 AKAP13	3.83e-05	197	283	11	6607_DN
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A	MTUS1 RABGAP1L PLCL2 NPTX1 TNC TRMO RIF1 PPP2R2B LMO7 AKAP13 ZNF839	3.83e-05	197	283	11	5823_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	AHI1 ZNF423 ASH1L ZYX AGO3 GFPT2 PPP2R2B VPS13D BCL11B LRP2 CSPP1	3.83e-05	197	283	11	1485_DN
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; PC3; HT_HG-U133A	SLCO2B1 PCNX2 PHLDB1 AGO4 TRMO MSX2 BCL11B BRF1 LMNA TIAM1 KIF13A	4.01e-05	198	283	11	6290_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	DCAF8 FRS2 MECP2 ZYX RABGAP1L ZSCAN5A ABLIM1 VPS13D BRF1 ARHGEF3 EIF4G3	4.01e-05	198	283	11	7023_DN
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ERCC4 MALT1 RABGAP1L KRAS TSC22D3 BCL11B LMNA SMARCA2 PCNX1 SPIDR RHOT1	4.01e-05	198	283	11	7353_UP
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A	AHI1 ERCC4 TENT5C THSD1 PHLDB1 VPS13A PPP4R4 FRMD4A RIF1 LMNA KIF13A	4.01e-05	198	283	11	3540_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	AHI1 SRPRA THSD1 VPS13A RBL1 TNPO2 LMNA POLR1E MICAL2 PCNX1 IKBKB	4.01e-05	198	283	11	5304_UP
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	FRS2 JADE1 MECP2 BPGM RABGAP1L MED12 HAUS5 TIAM1 SMARCA2 AKAP13 EIF4G3	4.20e-05	199	283	11	7203_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	TBC1D9B PALMD ZKSCAN5 PHF2 MBD4 TANK GPER1 RBL1 PRR7 BRF1 SMARCA2	4.20e-05	199	283	11	6740_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; PC3; HT_HG-U133A	TRIO CEP350 PCNX2 PHLDB1 NDNF CPS1 VPS13D TIAM1 SUSD5 SMARCA2 PCNX1	4.39e-05	200	283	11	6321_UP
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A	ABCC3 PALMD MTUS1 TANK GPER1 WEE1 RBL1 HAUS5 MFSD9 MED1 PRR7	4.39e-05	200	283	11	6298_DN
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZNF134 AHI1 CEP350 RABGAP1L VPS13A MBD4 NPTX1 APOE FRMD4A VPS13D CSPP1	4.39e-05	200	283	11	3442_DN
Drug	Succimer	CAND1 PUS3 LAYN ATRX CENPE ASH1L JADE1 CLPX MECP2 MALT1 SAMD9L UBXN2B STARD9 MKI67 UTRN CASP8AP2 VPS18 NPTX1 TANK TSC22D3 RBL1 ID3 WDPCP ANKRD44 RHOQ RIN1 RIF1 ABLIM1 ELL2 MICAL2 EXO1 AHNAK2	1.10e-04	1264	283	32	ctd:D004113
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	AHI1 ERCC4 ASH1L UTRN TANK RBL1 VPS13D PCNX1 SPIDR CSPP1	1.40e-04	190	283	10	3331_DN
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	TRIO ZYX PHF2 C17orf75 ARHGAP29 ID3 TRMO LMNB2 PRR7 ARHGEF3	1.40e-04	190	283	10	1103_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	TENT5C THSD1 KDR GFPT2 LIMA1 SORBS1 PPP2R2B TIAM1 VWA5A AHNAK2	1.46e-04	191	283	10	4302_UP
Drug	Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A	ATRX ASH1L FRS2 SRPRA THSD1 MTUS1 TANK APOE LMNA CSPP1	1.53e-04	192	283	10	3188_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ATRX TRIO CENPE BPGM MKI67 WEE1 TNPO2 SHB MED1 EIF4G3	1.53e-04	192	283	10	7176_DN
Drug	fdhR	UBR5 NEGR1	1.54e-04	2	283	2	CID006438762
Drug	APNPs	ABCC3 FRS2	1.54e-04	2	283	2	CID000005334
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	INTS1 NEB MECP2 VPS13A WEE1 HAUS5 VPS13D TIAM1 AKAP13 EIF4G3	1.59e-04	193	283	10	3412_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	AHI1 MALT1 PHLDB1 VPS13A MED23 UTRN TANK FRMD4A RIF1 KDSR	1.59e-04	193	283	10	6209_UP
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A	SLK TRIO GFPT2 GPATCH1 MFSD9 FAF1 RIN1 PCNX1 ZNF839 CDH7	1.66e-04	194	283	10	7558_DN
Drug	Nadide [53-84-9]; Up 200; 6uM; PC3; HT_HG-U133A	ABCC3 AGO4 RABGAP1L KRAS NPTX1 WEE1 LMNA MICAL2 VWA5A SMARCA2	1.66e-04	194	283	10	5873_UP
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	ABCC3 ERCC4 TIMELESS PDE11A CACNA2D1 SORBS1 RIF1 LMNA MICAL2 VWA5A	1.66e-04	194	283	10	4092_UP
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	PALMD AGO4 TIMELESS KRAS GPER1 TNPO2 VPS13D AKAP13 KIF13A CSPP1	1.66e-04	194	283	10	4264_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	INTS1 TENT5C THSD1 FANCA PLCL2 AMOTL2 TSC22D3 SHB CPS1 KIF13A	1.66e-04	194	283	10	3285_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A	CDK16 CENPE RNF40 MKI67 WEE1 VPS13D SMARCA2 PCNX1 AKAP13 ZNF839	1.66e-04	194	283	10	2009_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	CDK16 SLK AHI1 DCAF8 SRPRA BPGM VPS13D SMARCA2 EIF4G3 CSPP1	1.66e-04	194	283	10	1264_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	CDK16 ZKSCAN5 FANCA PHF2 SHB ID3 LMNB2 RIN1 BCL11B ZNF839	1.73e-04	195	283	10	6338_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; PC3; HT_HG-U133A	TBC1D9B ATRX CENPE RNF40 NIPBL MED12 TCTN1 TSC22D3 SHB VPS13D	1.73e-04	195	283	10	5850_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; PC3; HT_HG-U133A	SLK THSD1 MTUS1 UTRN KRAS TNC SORBS1 VPS13D PCNX1 AKAP13	1.80e-04	196	283	10	4218_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	ERCC4 WWC3 TRIO TENT5C SRPRA VPS13A GPER1 TRMO TIAM1 SMARCA2	1.80e-04	196	283	10	1654_UP
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	TRIO AGO4 TIMELESS NDNF NPTX1 TSC22D3 SORBS1 VWA5A LRP2 RGS17	1.80e-04	196	283	10	5910_UP
Drug	retinoic acid; Down 200; 1uM; HL60; HG-U133A	DCAF8 TRIO FSTL4 AGO4 ZNRD2 TSC22D3 CPA3 PPP2R2B LMNA MICAL2	1.80e-04	196	283	10	390_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	SLK MECP2 ZKSCAN5 TRMT9B RBL1 HAUS5 APOE KIF13A CSPP1 RPL13	1.80e-04	196	283	10	3167_DN
Drug	Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A	CAND1 ASH1L SRPRA UBR5 STK39 TCTN1 KTN1 MED1 CLASRP VPS13D	1.80e-04	196	283	10	1790_DN
Drug	1n9a	AHI1 SDHA KRAS WRN LMNB2 LMNA AKAP13	1.85e-04	95	283	7	CID004631604
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A	KDR TIMELESS KRAS COL11A1 GPER1 TNPO2 MYRIP BCL11B SUSD5 SPIDR	1.88e-04	197	283	10	4326_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	CDK16 DCAF8 INTS1 JADE1 ZKSCAN5 HAUS5 VPS13D BRF1 IKBKB CSPP1	1.88e-04	197	283	10	6222_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	AHI1 ATRX ASH1L SRPRA PHLDB1 UTRN HAUS5 FRMD4A LMNA SMARCA2	1.88e-04	197	283	10	3750_DN
Drug	Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DCAF8 NEB RABGAP1L TIMELESS TCTN1 WEE1 TNPO2 TRMO VPS13D VWA5A	1.88e-04	197	283	10	5536_DN
Drug	Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; PC3; HT_HG-U133A	PALMD ITPR3 FANCA MTUS1 TCTN1 GPER1 HAUS5 MFSD9 VPS13D ZNF839	1.88e-04	197	283	10	5887_DN
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A	ZKSCAN5 TIMELESS TCTN1 TPST1 GPER1 WEE1 SHB PRR7 MICAL2 AKAP13	1.88e-04	197	283	10	6443_DN
Drug	Gramine [87-52-5]; Down 200; 23uM; PC3; HT_HG-U133A	ABCC3 PALMD NEB ZKSCAN5 KRAS BRF1 PCNX1 ZFHX3 IKBKB ZNF839	1.88e-04	197	283	10	3999_DN
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A	ERCC4 ATRX FRS2 SRPRA NEB PLTP RIN1 BCL11B RGS20 LRP2	1.88e-04	197	283	10	3216_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	DCAF8 WWC3 ASH1L TSC22D3 WEE1 SHB PPP2R2B VPS13D MICAL2 RGS17	1.88e-04	197	283	10	6999_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	TRIO ZYX UTRN GPER1 SORBS1 MSX2 VPS13D VWA5A ZFHX3 KIF13A	1.88e-04	197	283	10	4336_DN
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	CDK16 INTS1 THSD1 ZKSCAN5 MTUS1 UTRN ABLIM1 BCL11B BRF1 CSPP1	1.88e-04	197	283	10	6359_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	AHI1 DCAF8 ZNF423 FRS2 ZYX MTUS1 UTRN HAUS5 LMNA ZFHX3	1.88e-04	197	283	10	1468_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	TBC1D9B INTS1 TCTN1 TPST1 LIMA1 ID3 CLASRP LMNA AKAP13 ZNF654	1.96e-04	198	283	10	1633_DN
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	ERCC4 NEB ZKSCAN5 RABGAP1L UTRN KRAS VPS13D MICAL2 PCNX1 IKBKB	1.96e-04	198	283	10	2799_DN
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	TRIO NEB ITPR3 CEP350 RABGAP1L VPS13A GFPT2 APOE VPS13D LMNA	1.96e-04	198	283	10	3281_DN
Drug	Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A	FANCA RABGAP1L KRAS TPST1 NPTX1 APOE PPP4R4 BCL11B BRF1 SMARCA2	1.96e-04	198	283	10	7332_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A	AHI1 ERCC4 NEB PPFIA4 PRR7 LMNA TIAM1 LBX1 ZFHX3 IKBKB	1.96e-04	198	283	10	2088_UP
Drug	Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MECP2 RABGAP1L MED12 KRAS TSC22D3 HAUS5 MICAL2 VWA5A PCNX1 IKBKB	1.96e-04	198	283	10	6505_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ZNF134 TENT5C NEB ZKSCAN5 NPTX1 TANK TRMO VWA5A SMARCA2 IKBKB	1.96e-04	198	283	10	1502_UP
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CDK16 MECP2 RABGAP1L MBD4 TANK WEE1 HAUS5 ABLIM1 ZNF839 CSPP1	1.96e-04	198	283	10	6252_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	DCAF8 PCNX2 PLCL2 MED12 GPER1 APOE RIN1 VPS13D KIF13A AHNAK2	2.04e-04	199	283	10	3287_UP
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; PC3; HT_HG-U133A	ASH1L MECP2 PCNX2 RABGAP1L TRMT9B PRR7 BRF1 TIAM1 LBX1 ZFHX3	2.04e-04	199	283	10	4635_DN
Drug	Magnetite Nanoparticles	CAND1 PUS3 LAYN ATRX CENPE ASH1L JADE1 CLPX MECP2 MALT1 SAMD9L UBXN2B STARD9 MKI67 UTRN CASP8AP2 VPS18 NPTX1 TANK TSC22D3 RBL1 ID3 WDPCP ANKRD44 RHOQ RIN1 RIF1 ABLIM1 ELL2 MICAL2 EXO1 AHNAK2	2.10e-04	1310	283	32	ctd:D058185
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ABCC3 MYH6 SLCO2B1 COL11A1 SORBS1 CPS1 RIF1 VPS13D VWA5A KIF13A	2.13e-04	200	283	10	5626_UP
Drug	5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA	ZNF423 ZNF223 FANCA GFPT2 PLTP NPTX1 TNPO2 VPS13D PCNX1 AKAP13	2.13e-04	200	283	10	885_UP
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A	AHI1 SLCO2B1 FRS2 ITPR3 PTPRB RABGAP1L UTRN PPP4R4 BRF1 PCNX1	2.13e-04	200	283	10	4588_UP
Drug	AC1L2AC7	RYR3 ITPR3 CACNA1E CACNA2D1 APOE LRP2	2.17e-04	69	283	6	CID000068733
Disease	prostate carcinoma	ABHD17A PRTG SLK TRIO ETV3 CEP350 NLGN3 DLGAP3 ANLN STK39 COL6A3 CACNA2D1 SHROOM3 GPER1 TNC USP28 WDPCP RIF1 ABLIM1 PPP2R2A LMNA LMO7 RGS17 ZFHX3 KIF13A KDSR DNAH11	1.14e-07	891	278	27	EFO_0001663
Disease	neuroticism measurement, cognitive function measurement	ERCC4 CTTNBP2 SDCCAG8 LRP1B PLCL2 CACNA1E NPTX1 TANK PCDHA10 STMND1 GRIK3 APOE WDPCP PPP2R2B BCL11B ASXL3 ZFHX3 EIF4G3 CDH7 CDH12	5.18e-07	566	278	20	EFO_0007660, EFO_0008354
Disease	Malignant neoplasm of breast	KDM3A TBC1D9B SLCO2B1 TRPC4 SPATA18 MKI67 ARHGAP29 KDR TIMELESS NIPBL MED12 KRAS COL11A1 TANK GPER1 KTN1 MFSD9 GRIK3 SORBS1 CLASRP RIF1 LBX1 DAW1 HEATR9 ANKRD30A EXO1 LRBA IKBKB	1.33e-06	1074	278	28	C0006142
Disease	dilated cardiomyopathy 1A (implicated_via_orthology)	LMNB2 LMNA DOT1L	3.29e-06	4	278	3	DOID:0110425 (implicated_via_orthology)
Disease	coronary artery calcification	PDE3A FSTL4 LRP1B HPCAL1 STARD9 PLTP CACNA1E CACNA2D1 MYRIP STMND1 APOE ELL2 ARHGEF3 CDH7 CDH12 PHACTR1	6.73e-06	450	278	16	EFO_0004723
Disease	Ciliopathies	AHI1 ZNF423 SDCCAG8 IFT43 TCTN1 LCA5 WDPCP DNAH11	1.00e-05	110	278	8	C4277690
Disease	Colorectal Carcinoma	ABCC3 NLGN4X VPS13A MKI67 KDR KRAS VPS18 SATB2 ZSCAN5A WRN GRIK3 LMNB2 BCL11B BRF1 TIAM1 LMO7 ANP32A EXO1 LRP2 CDH7	1.31e-05	702	278	20	C0009402
Disease	congenital muscular dystrophy (implicated_via_orthology)	COL6A3 LMNB2 LMNA	1.62e-05	6	278	3	DOID:0050557 (implicated_via_orthology)
Disease	diffuse plaque measurement	PRTG FSTL4 LRP1B PHF2 HPCAL1 KDR STK39 LNX1 PDE11A LCA5 COL6A3 SHROOM3 SDK2 SHB ZDBF2 APOE FRMD4A PPP2R2B BCL11B DNAH11	3.87e-05	758	278	20	EFO_0010699
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	KDM3A ERCC4 CTTNBP2 ZNF423 TRPC4 ZKSCAN5 KIF2B NEGR1 PLCL2 HERC1 UTRN PDE11A TRMT9B TANK USP28 WDPCP LRPPRC ZFHX3 ZNF654 PHACTR1	8.25e-05	801	278	20	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	deoxycytidine kinase measurement	APOE ARHGEF3	8.84e-05	2	278	2	EFO_0801523
Disease	Werner syndrome (is_implicated_in)	WRN LMNA	8.84e-05	2	278	2	DOID:5688 (is_implicated_in)
Disease	breast cancer (is_implicated_in)	FANCA UBR5 MKI67 KRAS WRN APOE PPP2R2B IKBKB	9.31e-05	150	278	8	DOID:1612 (is_implicated_in)
Disease	f-box/LRR-repeat protein 4 measurement	PLTP APOE ARHGEF3	9.45e-05	10	278	3	EFO_0802538
Disease	Intellectual Disability	CDK16 AHI1 PUS3 TRIO SDCCAG8 ASH1L MECP2 MED23 TCTN1 CACNA1E BCL11B BRF1 LRP2 PHACTR1	9.90e-05	447	278	14	C3714756
Disease	Craniofacial Abnormalities	ATRX MECP2 NIPBL SATB2 COL11A1 MSX2 LMNA LRP2	1.22e-04	156	278	8	C0376634
Disease	cortical thickness	PRTG CTTNBP2 ZNF423 POLR2M PHLDB1 BPGM DIAPH3 PDGFC LNX1 AGAP3 TRMT9B SATB2 SHROOM3 COL11A1 CPA3 APOE FAF1 MBLAC1 PPP2R2A VPS13D BCL11B EIF4G3 KIF13A INS-IGF2	1.56e-04	1113	278	24	EFO_0004840
Disease	phenylalanine measurement	VAPA VPS18 APOE CPS1 KIF13A	1.70e-04	55	278	5	EFO_0005001
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR3 PPP2R2A PPP2R2B	1.71e-04	12	278	3	DOID:1441 (implicated_via_orthology)
Disease	Hyperlipoproteinemia Type IIb	PON2 APOA4 APOE	2.21e-04	13	278	3	C1704417
Disease	brain measurement, neuroimaging measurement	PRTG CTTNBP2 SDCCAG8 POLR2M PDGFC LNX1 COL11A1 TANK GPATCH1 KTN1 FAF1 BCL11B SMARCA2 ZFHX3 DNAH11	2.54e-04	550	278	15	EFO_0004346, EFO_0004464
Disease	Lujan Fryns syndrome	UPF3B MED12	2.64e-04	3	278	2	C0796022
Disease	dementia, Parkinson disease, disease progression measurement	LRP1B APOE	2.64e-04	3	278	2	EFO_0008336, MONDO_0001627, MONDO_0005180
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13A VPS13D	2.64e-04	3	278	2	DOID:0111611 (implicated_via_orthology)
Disease	serum VEGFR2 concentration measurement	KDR LNX1	2.64e-04	3	278	2	EFO_0006795
Disease	autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology)	LMNB2 LMNA	2.64e-04	3	278	2	DOID:0070248 (implicated_via_orthology)
Disease	congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology)	LMNB2 LMNA	2.64e-04	3	278	2	DOID:0110640 (implicated_via_orthology)
Disease	Rare dyslipidemia	APOA4 APOE	2.64e-04	3	278	2	Orphanet_101953
Disease	familial partial lipodystrophy type 2 (implicated_via_orthology)	LMNB2 LMNA	2.64e-04	3	278	2	DOID:0070202 (implicated_via_orthology)
Disease	breast angiosarcoma (is_implicated_in)	PTPRB KDR	2.64e-04	3	278	2	DOID:4511 (is_implicated_in)
Disease	autosomal dominant cerebellar ataxia (is_implicated_in)	SAMD9L NPTX1	2.64e-04	3	278	2	DOID:1441 (is_implicated_in)
Disease	autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology)	LMNB2 LMNA	2.64e-04	3	278	2	DOID:0070247 (implicated_via_orthology)
Disease	FEV/FEC ratio	VAPA ABHD17A PDE3A CTTNBP2 DCAF8 WWC3 NEB IFT43 SPTBN5 PHF2 MTUS1 NEGR1 KDR DENND5A HERC1 LNX1 AGAP3 COL6A3 ZNRD2 SHB FAF1 FRMD4A TBCK ZFHX3 KIF13A	2.73e-04	1228	278	25	EFO_0004713
Disease	parental longevity	PDE3A CTTNBP2 LRP1B RYR3 CEP350 KIF2B VPS13A SHROOM3 GPATCH1 LMNB2 APOE CPS1 TCP11L2 SMARCA2	2.77e-04	494	278	14	EFO_0007796
Disease	blood barium measurement	IFT43 NEGR1 CACNA2D1 TIAM1	2.86e-04	34	278	4	EFO_0021528
Disease	differentiated thyroid carcinoma	SLK PCNX2 TRMO FAF1	3.21e-04	35	278	4	EFO_1002017
Disease	gestational age	UBR5 NEGR1 UTRN FAF1 ANKRD44 CKAP2L PCNX1	3.47e-04	138	278	7	EFO_0005112
Disease	Hyperlipoproteinemia Type IIa	PON2 APOA4 APOE	4.23e-04	16	278	3	C0745103
Disease	neurodegenerative disease (implicated_via_orthology)	VAPA TRPC4 SDHA PON2 GRIK3 BCL11B RHOT1	4.67e-04	145	278	7	DOID:1289 (implicated_via_orthology)
Disease	lung cancer (is_marker_for)	ERCC5 MKI67 KRAS TNC	4.89e-04	39	278	4	DOID:1324 (is_marker_for)
Disease	intrahepatic cholangiocarcinoma (is_implicated_in)	LRP1B KRAS	5.24e-04	4	278	2	DOID:4928 (is_implicated_in)
Disease	DNA methylation	ERCC4 TRIO ZNF423 POLR2M LRP1B PHF2 RABGAP1L LNX1 MYRIP STMND1 ANKRD44 RESF1 TIAM1 SMARCA2 ZNF839 DNAH11	5.45e-04	656	278	16	GO_0006306
Disease	serum urea measurement	ASH1L FANCA UBE2Q2 SHROOM3 APOE CPS1 LMNA INS-IGF2	5.53e-04	195	278	8	EFO_0009795
Disease	gallstones	UBXN2B SHROOM3 APOE CPS1 ARHGEF3 LRBA	5.68e-04	108	278	6	EFO_0004210
Disease	Hemangiosarcoma	PTPRB KDR KRAS	6.08e-04	18	278	3	C0018923
Disease	Hypercholesterolemia, Familial	PON2 APOA4 APOE	6.08e-04	18	278	3	C0020445
Disease	autism spectrum disorder (implicated_via_orthology)	TRPC4 ASH1L ITPR3 NLGN3 NLGN4X NLGN4Y LRBA	6.19e-04	152	278	7	DOID:0060041 (implicated_via_orthology)
Disease	receptive language perception	MALT1 STK39 MYRIP	7.17e-04	19	278	3	EFO_0005686
Disease	leukemia (implicated_via_orthology)	ASH1L KRAS DOT1L	7.17e-04	19	278	3	DOID:1240 (implicated_via_orthology)
Disease	glioblastoma (is_marker_for)	ATRX PTPRB KRAS TNC	7.78e-04	44	278	4	DOID:3068 (is_marker_for)
Disease	depressive symptom measurement	ERCC4 CTTNBP2 PHF2 NEGR1 PLCL2 HERC1 MED12 CACNA1E GRIK3 WDPCP ASXL3 EIF4G3	7.87e-04	426	278	12	EFO_0007006
Disease	Adenocarcinoma of lung (disorder)	SLK KDR STK39 MYO18B KRAS LMNA ANP32A DOT1L	7.91e-04	206	278	8	C0152013
Disease	brain glioma (is_marker_for)	PTPRB KDR	8.68e-04	5	278	2	DOID:0060108 (is_marker_for)
Disease	sarcoma (is_marker_for)	ATRX KDR	8.68e-04	5	278	2	DOID:1115 (is_marker_for)
Disease	asthma, Eczema	LRP1B TBC1D14	8.68e-04	5	278	2	HP_0000964, MONDO_0004979
Disease	proteasome activator complex subunit 1 measurement	APOE ARHGEF3	8.68e-04	5	278	2	EFO_0020661
Disease	aconitate measurement	BSPRY SDCCAG8	8.68e-04	5	278	2	EFO_0010451
Disease	spermidine measurement	TRIM58 ARHGEF3	8.68e-04	5	278	2	EFO_0021802
Disease	low-density lipoprotein receptor-related protein 1B measurement	APOE ARHGEF3	8.68e-04	5	278	2	EFO_0021873
Disease	platelet component distribution width	AHI1 SDCCAG8 TENT5C HPCAL1 TBC1D14 HERC1 VPS18 TANK TRIM58 WEE1 TRMO APOE CPS1 BRF1 PHACTR3 AKAP13 ARHGEF3	8.94e-04	755	278	17	EFO_0007984
Disease	Joubert syndrome 1	AHI1 TCTN1 CSPP1	9.70e-04	21	278	3	C4551568
Disease	muscular dystrophy (implicated_via_orthology)	UTRN LMNB2 LMNA	9.70e-04	21	278	3	DOID:9884 (implicated_via_orthology)
Disease	sugar consumption measurement	TRIO FSTL4 TANK APOE LRPPRC ASXL3	9.87e-04	120	278	6	EFO_0010158
Disease	ovarian carcinoma	KDM3A ZNF423 UPF3B POU2AF1 LRPPRC LMNA TIAM1 ASXL3 ZFHX3 EIF4G3	1.01e-03	321	278	10	EFO_0001075
Disease	Ischemic stroke	PDE3A LPCAT2 LNX1 COL6A3 USP28 KTN1 LMNA PCNX1 ZFHX3 DNAH11	1.08e-03	324	278	10	HP_0002140
Disease	unipolar depression	ERCC4 CTTNBP2 TRIO MRPL37 ASH1L NEGR1 ALPK3 PDGFC MED12 CACNA1E CASP8AP2 CACNA2D1 COL11A1 TNC STMND1 GRIK3 WDPCP ANKRD44 MICAL2 ASXL3 SMARCA2 ZFHX3 EIF4G3	1.15e-03	1206	278	23	EFO_0003761
Disease	lung adenocarcinoma (is_implicated_in)	LRP1B UBR5 KRAS ZFHX3	1.17e-03	49	278	4	DOID:3910 (is_implicated_in)
Disease	severe acute respiratory syndrome, COVID-19	ABCC3 POLR2M LRP1B TRMT9B COL6A3 CACNA2D1 WRN MYRIP ABLIM1 RGS17 ZFHX3 ARHGEF3	1.19e-03	447	278	12	EFO_0000694, MONDO_0100096
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC4 ERCC5	1.29e-03	6	278	2	DOID:2962 (implicated_via_orthology)
Disease	lung adenocarcinoma	PDE3A SLK PHLDB1 MTUS1 PDGFC TRMT9B MICAL2	1.36e-03	174	278	7	EFO_0000571
Disease	mood instability measurement	LRP1B IFT43 NEGR1 RABGAP1L PLCL2 LMNB2	1.38e-03	128	278	6	EFO_0008475
Disease	aspartate measurement	GRIK3 CPS1 ARHGEF3	1.45e-03	24	278	3	EFO_0010462
Disease	Dyslipidemias	PLTP APOE DNAH11	1.45e-03	24	278	3	C0242339
Disease	Dyslipoproteinemias	PLTP APOE DNAH11	1.45e-03	24	278	3	C0598784
Disease	FEV change measurement, response to zileuton	SDK2 CPS1 PCNX1	1.63e-03	25	278	3	EFO_0005921, EFO_0007676
Disease	Left ventricular mass to end-diastolic volume ratio	ALPK3 MYO18B FAF1	1.63e-03	25	278	3	EFO_0010556
Disease	alcohol consumption measurement	ERCC4 CTTNBP2 SDCCAG8 JADE1 SPTBN5 DLGAP3 PTPRB NEGR1 RABGAP1L MBD4 CACNA1E USP28 CPS1 MED1 WDPCP FAF1 FRMD4A PPP2R2A LRPPRC BCL11B AATF ZFHX3 PHACTR1	1.68e-03	1242	278	23	EFO_0007878
Disease	Metastatic melanoma	TRIO STRADB ALPK3 OXSR1	1.68e-03	54	278	4	C0278883
Disease	Small cell carcinoma of lung	MYO18B SATB2 ZDBF2 GRIK3	1.68e-03	54	278	4	C0149925
Disease	serum metabolite measurement	PDE3A ERCC4 TRIO PARP4 RABGAP1L STK39 LNX1 PLTP CACNA1E CACNA2D1 TRIM58 APOE CPS1 LRPPRC BCL11B MROH1 ZFHX3 INS-IGF2 PHACTR1	1.70e-03	945	278	19	EFO_0005653
Disease	Autism spectrum disorder	MECP2 NLGN4X	1.80e-03	7	278	2	cv:C1510586
Disease	Joubert syndrome (implicated_via_orthology)	AHI1 TOGARAM1	1.80e-03	7	278	2	DOID:0050777 (implicated_via_orthology)
Disease	E3 ubiquitin-protein ligase ZNRF3 measurement	PPP4R4 ARHGEF3	1.80e-03	7	278	2	EFO_0021943
Disease	Antithrombotic agent use measurement	APOA4 APOE ZFHX3 PHACTR1	1.80e-03	55	278	4	EFO_0009925
Disease	Neurodevelopmental Disorders	TRIO ASH1L MECP2 PHF2 ASXL3	1.89e-03	93	278	5	C1535926
Disease	mean corpuscular hemoglobin concentration	SLK TENT5C CLPX NEB AGO4 UBR5 PLCL2 VPS13A OXSR1 SLC22A20P TRIM58 RBL1 CPS1 RIF1 ELL2 BRF1 EXO1 AKAP13 DOT1L EIF4G3 ZNF654	1.95e-03	1105	278	21	EFO_0004528
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC5 LRP1B PTPRB KDR SDHA ZFHX3	2.09e-03	139	278	6	DOID:3908 (is_implicated_in)
Disease	HMG CoA reductase inhibitor use measurement	ITPR3 UBXN2B APOA4 APOE LRPPRC PCNX1 DNAH11	2.18e-03	189	278	7	EFO_0009932
Disease	Malignant neoplasm of prostate	SPATA18 ASH1L ETV3 LRP1B MED12 KRAS USP28 EI24 ID3 PPP2R2A LRP2 AKAP13 ZFHX3 CDH12	2.29e-03	616	278	14	C0376358
Disease	Prostatic Neoplasms	SPATA18 ASH1L ETV3 LRP1B MED12 KRAS USP28 EI24 ID3 PPP2R2A LRP2 AKAP13 ZFHX3 CDH12	2.29e-03	616	278	14	C0033578
Disease	physical activity measurement	ZKSCAN5 NEGR1 RABGAP1L HERC1 APOE LRPPRC SMARCA2 PHACTR1	2.37e-03	245	278	8	EFO_0008002
Disease	Alzheimer's disease biomarker measurement, brain volume measurement	KRAS APOE	2.39e-03	8	278	2	EFO_0006514, EFO_0006930
Disease	arteriosclerosis (biomarker_via_orthology)	KDR LMNA	2.39e-03	8	278	2	DOID:2349 (biomarker_via_orthology)
Disease	P wave terminal force measurement	MYH6 ALPK3	2.39e-03	8	278	2	EFO_0008379
Disease	cerebrovascular disease (is_implicated_in)	APOE LMNA	2.39e-03	8	278	2	DOID:6713 (is_implicated_in)
Disease	dynein light chain roadblock-type 1 measurement	TRIM58 ARHGEF3	2.39e-03	8	278	2	EFO_0008114
Disease	progeria (implicated_via_orthology)	LMNB2 LMNA	2.39e-03	8	278	2	DOID:3911 (implicated_via_orthology)
Disease	selenium measurement	SDCCAG8 CMYA5 ANKRD44	2.52e-03	29	278	3	EFO_0006331
Disease	peripheral arterial disease, traffic air pollution measurement	AHI1 NEGR1 HPCAL1 UTRN CCDC57 FRMD4A LRBA	2.52e-03	194	278	7	EFO_0004265, EFO_0007908
Disease	Familial aplasia of the vermis	AHI1 TCTN1 CSPP1	2.78e-03	30	278	3	C0431399

Protein segments in the cluster

Peptide	Gene	Start	Entry
DVVTTNLKLRNPSDR	VAPA	31	Q9P0L0
QSKESELRILDEIPT	TDRD5	711	Q8NAT2
EERSQPVKLESTRTT	TPST1	36	O60507
PELSALRLSEQLREK	AMOTL2	541	Q9Y2J4
NPRVIDDSRARKLST	AGAP3	206	Q96P47
RDVTLEASRENSKPR	PPP2R2B	371	Q00005
TNERLKVALRSLPEE	RNF40	366	O75150
RKESLPSNERAVQTL	ASH1L	1646	Q9NR48
KIEEESPLDRRNFIS	CFAP43	291	Q8NDM7
RDAVSSPQKRLLDSE	ELL2	311	O00472
LSQLRDVRKPDGSTE	ARHGEF3	181	Q9NR81
TPVAEETRARLSKEL	APOE	101	P02649
ERASAQSSTEKLIRP	CXorf66	126	Q5JRM2
QERQSLEPEVSELKS	CACNA1E	1961	Q15878
EKQTSLTPRELEIRR	CLPX	216	O76031
DKQERQSLGESPRTL	ABLIM1	416	O14639
DITLEASRENNKPRT	PPP2R2A	376	P63151
KLVRSEENISPDTIR	AHI1	36	Q8N157
LTTVDTRRSPDVLKD	CLIC3	41	O95833
SEKDPESLRQSAREK	ETV3	386	P41162
VTILAATNRPDRIDK	SPATA5	766	Q8NB90
KERPRSAVLLVDETA	AKAP13	1871	Q12802
SLSRPSSLIEQEKQR	AKAP13	2561	Q12802
EVDTLRKLSPDRFQR	ALPK3	411	Q96L96
KPELEKAAQSRRSSE	ALPK3	531	Q96L96
EQTLRADEILPSESK	ANKRD30A	781	Q9BXX3
SRQRATDELFEPLKE	DNAH11	1181	Q96DT5
RELDTIEVFPTKSAR	ABHD17A	81	Q96GS6
LRNRTPSDVKELVLD	ANP32A	11	P39687
DPESEAKRRIVFTIT	DOT1L	1036	Q8TEK3
IKATARSAPDRQEEI	AGO3	366	Q9H9G7
KATARSAPDRQEEIS	AGO4	356	Q9HCK5
SAPDRQEEISRLVKS	AGO4	361	Q9HCK5
EERSLSLLAKAVDPR	DIAPH3	266	Q9NSV4
ATLKPERSFEILTEQ	CASP8AP2	1281	Q9UKL3
LLRDSTTDSKENPSR	ETNPPL	466	Q8TBG4
RVVLTPLKVSDEQSD	ASXL3	181	Q9C0F0
PSRTVDTKQAQDLAR	KRAS	121	P01116
LADSPREESNKRQRT	RBM45	461	Q8IUH3
PKEVSLDSRVREVIN	RGS17	146	Q9UGC6
NSDILIRTELRPVKE	ITPR3	661	Q14573
LSQEELDPQSVERKT	ABCC3	606	O15438
RLTAPEDVFSKLQRE	NUP205	1451	Q92621
QEKTLQRAPTISERA	OXSR1	301	O95747
QLRSPRVKESISNSE	OXSR1	356	O95747
PRNDTEERVKIETAL	NPTX1	191	Q15818
TPRNFSVSIREELKR	PDGFC	251	Q9NRA1
KIDQTVEELRRSLAP	APOA4	211	P06727
KLPTEITRVSDEELN	C8orf48	106	Q96LL4
ELLRQASERNSKSPT	PALMD	241	Q9NP74
ERELDTVKNPTRSLD	OTOP3	401	Q7RTS5
PVKDLTLRNRSTEDL	PTPRB	821	P23467
LSPTRITRLQEKEDL	LMNA	21	P02545
RTRIIDSKTEQPAAL	LRP1B	361	Q9NZR2
NRREEKEETLVIPST	LTV1	91	Q96GA3
NLELPRLSETSIKDR	LIMA1	256	Q9UHB6
SVDPRVSISTLNKRD	NEGR1	86	Q7Z3B1
PVTEDESLQSLKARI	IKBKB	326	O14920
LDEEVSRTLNAETPK	MEPCE	201	Q7L2J0
RLAEAAVAEKRAISP	INTS1	91	Q8N201
RSSLSEKRALTDPIQ	MALT1	551	Q9UDY8
SAPRLVSETAERKQE	MFSD9	11	Q8NBP5
TVLSRTPRSDLNADK	MTUS1	551	Q9ULD2
RKQSEADLAETRPDL	LAYN	296	Q6UX15
LSPTRLSRLQEKEEL	LMNB2	36	Q03252
SPVSREENREDKATI	PPFIA4	681	O75335
DSKVPSLQDTFDRER	SPATA18	96	Q8TC71
VSTPRLELKDTSRSD	ANLN	626	Q9NQW6
SRSDENVLDSPKQRR	KIAA1109	1346	Q2LD37
RLIKSRSESDLSQPE	HERC1	1506	Q15751
EQLSSFDISPREKLI	ARNTL2	241	Q8WYA1
SPALISRFKEREENV	CAND1	376	Q86VP6
TTKPLDRSERAIVDT	COL11A1	186	P12107
TADVSPQELLRRLKS	GPATCH1	911	Q9BRR8
QRRGLDPVSELESSK	PCNX1	306	Q96RV3
PEKLRNSVSERLQSD	PCNX1	1251	Q96RV3
SERTPERLKTRVSTN	PCNX2	451	A6NKB5
VIEKNRPADVRASTA	PLTP	471	P55058
INERTDKDSRLPLIL	RHOT1	101	Q8IXI2
LTPSAIFDRNRKDEL	PDE11A	851	Q9HCR9
APVRRDRSTSIKLQE	PDE3A	456	Q14432
NRKEIRTILSELAPS	COMMD2	106	Q86X83
EDKRAVVSLDPNLAT	CSPP1	711	Q1MSJ5
IDLRQDRPASKLVVT	DCAF8	311	Q5TAQ9
SKLRPEVLQDLRENT	HPCAL1	6	P37235
DPKTVLSAESEELNR	MED23	671	Q9ULK4
SESRLAESKPNENRL	NIPBL	616	Q6KC79
EEIQKAEPLLTASRT	DAW1	46	Q8N136
LPAQDKIRSRDASED	NCBP3	181	Q53F19
TDTERLELKASPNVE	LRBA	1251	P50851
DLSRNLIRKIPDSIS	LRRC18	56	Q8N456
AKREDRVTTEIQLPS	LMO7	851	Q8WWI1
KINRVDPSESLSIRL	LNX1	276	Q8TBB1
SSRTQKLPTRDEELF	NDNF	16	Q8TB73
TAQKRPENSLLEETL	MPHOSPH10	391	O00566
PLNVVETSSSVRERK	KTN1	101	Q86UP2
QSLNREPLRKDTDLV	LCA5	86	Q86VQ0
STLETLKAENQPIRD	LRPPRC	666	P42704
ERQSDSLEKVRQLLP	MED12	1626	Q93074
SSVASDNAIRRIKPD	LRP2	2116	P98164
TEDVNTLDSEKRTPL	ANKRD44	31	Q8N8A2
SLRTSAKRIEPAEEL	MKI67	3051	P46013
QLPRSESLKDVLERL	BPGM	151	P07738
SPQVRRKLELEAAVT	HAUS5	71	O94927
QDESLTLQLVKRSRP	PARP4	981	Q9UKK3
DPKADSVRAISVRTL	MROH1	456	Q8NDA8
NTDLSRILKSPEIQR	RPL4	286	P36578
LPTIASREEIEATKN	MRPL37	236	Q9BZE1
NEKLLPETVTIDSER	C17orf75	131	Q9HAS0
LSPEARRSLEKEKNS	CCDC167	41	Q9P0B6
EILRDSEKRPSSLLV	RABGAP1L	61	Q5R372
RFSVTEQKLSIPESR	PCDHA10	131	Q9Y5I2
EQKLSIPESRLLDSR	PCDHA10	136	Q9Y5I2
TRKLSQRPTVEELRE	PHACTR1	501	Q9C0D0
VTPFLSRRDSAEKQE	PRR7	181	Q8TB68
ELAVLPKETSESNQR	PRTG	911	Q2VWP7
LVSRVDPDSRKNTIN	LPCAT2	186	Q7L5N7
EDPRRAASSLTIDKL	POU2AF1	221	Q16633
NRLKASREVESVDLP	PON2	26	Q15165
NPETRRKTLVALFTD	NLGN3	466	Q9NZ94
ENPETRRKTLVALFT	NLGN4Y	431	Q8NFZ3
LRLPVSRETKSFENV	ARHGAP29	161	Q52LW3
STPETLLEEIEAKNR	UPF3B	176	Q9BZI7
LAEDRLPRETLQFSK	WDPCP	416	O95876
TEAARRLASDPNVSK	FRMD4A	476	Q9P2Q2
LEVSELATVKRPQER	ATRX	1651	P46100
NLDLRKELSEPSSTR	CPS1	836	P31327
ERVTSPRIEAASQKR	IGSF10	1936	Q6WRI0
KASEEIEDFRLRPQS	IFT43	76	Q96FT9
QSLKRLFIERPEDET	SLC25A30	91	Q5SVS4
LAERKSPEISERIVQ	KDM3A	96	Q9Y4C1
ERTVSPFLQLSDDRK	BSPRY	236	Q5W0U4
SSRSELRKVSEPVEI	BCL11B	101	Q9C0K0
ATTLAIAPVRFDREK	CPA3	11	P15088
KRSASDDPSRAIQTL	GFPT2	296	O94808
DVSLEDIKRLTPRFT	CACNA2D1	491	P54289
TEDINKRLSLPADIR	CDK16	111	Q00536
SRDVSPTSRDNLVAK	CTTNBP2	471	Q8WZ74
EEERKLFSVPSQLRA	C19orf44	246	Q9H6X5
DSDERRDAPSVNKLV	FRS2	291	Q8WU20
SIERKQESEPRIVSR	EI24	56	O14681
VPDSRVAFIESLKRA	FANCA	596	O15360
TSEFLSKVPDEVRQR	LINC00032	31	P0C843
LDSNLTRAVKEEIPT	CMYA5	1361	Q8N3K9
SSLLREESQNEEIKP	CMYA5	1701	Q8N3K9
IRSRILKNAESDPRS	CRACD	671	Q6ZU35
PETAVSRLERREQLK	CRACD	1156	Q6ZU35
DSRQDPASQKRLLVE	FSTL4	166	Q6MZW2
SLDEISQPAQELKRS	COL6A3	561	P12111
VPVKERSLDSVDRQR	DLGAP3	926	O95886
PDFVKQLRTRTETDR	CEP350	1486	Q5VT06
QLRTRTETDRKSPSV	CEP350	1491	Q5VT06
EISKDFPSSEIQRLR	CCDC57	511	Q2TAC2
VSLEKLEVREDPSSN	DENND5A	481	Q6IQ26
EDTIPRTQIERRKTS	MBD4	401	O95243
LSEDPAAQERSRKRV	MBLAC1	206	A4D2B0
TLRAQAVDIETRKPL	CDH12	126	P55289
TAELTPELVISNDKR	ID3	101	Q02535
RSPQRLKETRISFVE	AHCTF1	1221	Q8WYP5
RRDVTQLDPNKSLLE	FAF1	621	Q9UNN5
FSIEDILNKPSVRRS	LBX1	36	P52954
KTRRDVTPEIQFLSR	CDH7	681	Q9ULB5
VRTPKDIASENSISR	CLIP3	516	Q96DZ5
RLKIRQLPIDSDDSR	GRIK3	201	Q13003
EEVRRKSELFNPVSL	POLR2M	66	P0CAP2
NRETDTKRPDARLAA	CEP295	201	Q9C0D2
EKSEEISLQQLRASP	SLC22A20P	536	A6NK97
AAEALVVTTEKRDRP	SDK2	1386	Q58EX2
RREETKAEAPLLTQT	SCNM1	96	Q9BWG6
TEAERNKTRESAKPE	EIF4G3	1191	O43432
EENRTKPLETRLISE	KDSR	226	Q06136
ENPETRRKTLVALFT	NLGN4X	431	Q8N0W4
DIVESSSPRKRENTV	PROCA1	321	Q8NCQ7
SLPSEVERLRKEIQD	CENPE	751	Q02224
LELNISKSVTREDAP	MAP3K19	166	Q56UN5
ISVDPRRRNKSTESL	RPL13	96	P26373
PSKRRVRFQEIDDSL	CNST	641	Q6PJW8
TPKTRREAEDLQASA	INS-IGF2	51	F8WCM5
RPLNQRETTLKDLDI	KIF2B	221	Q8N4N8
IRRKAETIQADTPAL	MED1	511	Q15648
RSVNLSRKESDIRPS	MICAL2	506	O94851
EASASPKQRRSIIRD	MECP2	76	P51608
EERRVKVSSLPFSVE	MSX2	36	P35548
LSNSRVLEKEVSRSP	KIF13A	1576	Q9H1H9
QESRRKTSRTEIPAL	NRIP2	146	Q9BQI9
LSKRLSQRPAVEELE	PHACTR3	441	Q96KR7
KSLPSDVESRDRQAR	POLR1E	261	Q9GZS1
SSRELVEPKLAELNR	UTRN	1721	P46939
TQIDLRDDPKTLARL	RHOQ	121	P17081
SEEAPKQDRLVSISV	SUSD5	241	O60279
VKASPRDIREQSETT	RIN1	741	Q13671
TLEEENTNLETPTKR	PUS3	456	Q9BZE2
VADTRRLNSKPQDLT	SNX12	6	Q9UMY4
DSESTVSPRLRESKL	SHB	311	Q15464
RINSTATPDQDRDKI	SLK	1091	Q9H2G2
KELRSRTFPSAEDVV	PHF2	91	O75151
RSLKTPEEIERLTVD	PPP4R4	36	Q6NUP7
SSRQETEEKILLDPN	SMARCA2	651	P51531
RTKFQEILEETPSAL	TCP11L2	246	Q8N4U5
ERENTLLKTLASPEQ	TSC22D3	91	Q99576
APVAKDLASRDVVSR	SDHA	331	P31040
RVIAIDSDAESPAKR	RBL1	1031	P28749
GVTSEESERNLRKPL	SPATA31A6	691	Q5VVP1
ANLVRKDREELSPTF	PIWIL2	106	Q8TC59
ILSPKEVSLDSRVRE	RGS20	321	O76081
EDEISSPVNKVRRVS	RIF1	2191	Q5UIP0
ERESISLTKLESSPR	RESF1	1591	Q9HCM1
RSRNPDESAKLADSI	SAMD9L	841	Q8IVG5
LRQQADKESEVSPSR	SDCCAG8	81	Q86SQ7
VEKVRLTERPENLSS	SEL1L2	261	Q5TEA6
ESVSEGLNVPRSKRL	PPP1R35	146	Q8TAP8
LKAVIPDSTEQSDVR	GPER1	356	Q99527
RRSLEVIPEKANDET	PLCL2	1111	Q9UPR0
VTSEELERNLRKPLR	SPATA31A7	696	Q8IWB4
KRDEALPSLTQVRRE	ERCC5	126	P28715
EILRKEEDPRTASQS	SATB2	396	Q9UPW6
RSSPATADKRQDVLL	SHROOM3	1241	Q8TF72
VPLLEDSETRKNNLT	TANK	76	Q92844
ENPRRVSILLKDISE	WRN	276	Q14191
EPKDVNREFRLTESS	STARD9	3026	Q9P2P6
QLRKDVVETTRSPES	STARD9	4311	Q9P2P6
DRKPSEVFRTDLITA	JADE1	41	Q6IE81
KERLEAQTRPFDIRT	MYH6	21	P13533
IVKRPRSAELSEDDL	EXO1	416	Q9UQ84
KSLREPLQERRTALE	SPTBN5	2876	Q9NRC6
LVRDFRPTDQEEIKT	TENT5C	251	Q5VWP2
SLEDTAKRSVVRAIP	TBC1D9B	796	Q66K14
RKDRVEISPEQLSAA	BRCC3	86	P46736
KEDDLDVVLSPQRRS	EIF4ENIF1	106	Q9NRA8
LIERKTSSLDPNDQV	AATF	471	Q9NY61
SAARTELILPEQDRK	AHNAK2	5766	Q8IVF2
LRNRTPSDVKELFLD	ANP32D	11	O95626
EREQVTATPRIAKAE	CKAP2L	641	Q8IYA6
LLTTISPEQESDERK	CLASRP	96	Q8N2M8
VRRKQSDSDLIPERA	TBC1D14	86	Q9P2M4
IESTARRTENPTKNE	XIRP2	2951	A4UGR9
VTSEELERNLRKPLR	SPATA31A3	696	Q5VYP0
SPDEAVRESSRIIKN	TIMELESS	456	Q9UNS1
SENRISPLVKDTRQS	TLR8	426	Q9NR97
DPNLTSVLERLEDTK	UBE2Q2	76	Q8WVN8
AKRAIEAVLSADPRS	TRMO	371	Q9BU70
DETRPAKRITITESN	WEE1	276	P30291
EAATRKQRITETESP	TYROBP	76	O43914
IATEPSSRARKVLEE	ZFR2	506	Q9UPR6
EIASDLTRPQDSTIK	ZNF223	106	Q9UK11
ASSKLLIQVERSEDP	VPS13A	2351	Q96RL7
DDSVPTTKIQIRLAD	UBXN2B	251	Q14CS0
VRREDFAPSRKLNTE	TIAM1	1576	Q13009
VTSEESERNLRKPLR	SPATA31A1	696	Q5TZJ5
VTSEELERNLRKPLR	SPATA31A5	696	Q5VU36
RTKESRSSPAVEQQL	SLCO2B1	681	O94956
TDVTLQTKEERDPRL	SPIDR	676	Q14159
QPRRSVDEELSKKSQ	PPP1R2B	31	Q6NXS1
SRNALTERSKLEDDP	RYR3	3561	Q15413
TVERDPRTAAVAEKL	TOMT	161	Q8WZ04
KELRRQNEDIEPTSS	WDR70	71	Q9NW82
DVSLSPEERVRALSK	STAMBPL1	21	Q96FJ0
NSRQPLEIRTSKRTE	THSD1	181	Q9NS62
VLTRLKSEDEPTRSL	TNPO2	51	O14787
KQRIDFTPSERITSL	VPS18	46	Q9P253
QKRLSSLSDPVSERR	SORBS1	321	Q9BX66
TPNEIKTLRENSELA	TERB2	121	Q8NHR7
RELTKSLESPREDEQ	HEATR9	151	A2RTY3
DLNSQRILTPEATKE	ERVK-10	301	P10266
KTLTRREDTDVLQPT	TCTN1	296	Q2MV58
KRVTTTRLDAPSQIE	TNC	796	P24821
PSSVRDDLKDVSSQR	ZSCAN5A	151	Q9BUG6
PLQSVADRLRETVKE	ZDBF2	1206	Q9HCK1
SDPALKIDTNRIRTE	ZNF654	991	Q8IZM8
LREAEESSKIRAPTT	SRPRA	121	P08240
RTLKRSLQPVVEDVS	VWA5A	456	O00534
SLLTDERVKEPSQDT	USP28	56	Q96RU2
DLRVPVTRERKNSIT	PHLDB1	566	Q86UU1
SRESIPLNDLKSEVS	TBCK	746	Q8TEA7
RKRLTEFEDTPTSQL	BRF1	261	Q92994
KRREPIQASTAREAI	BRF1	511	Q92994
LAVQRKSTERLEPAS	MYO18B	2211	Q8IUG5
PTEAETKVLQARRER	ZNRD2	16	O60232
SVKRPRREALSNDTT	ZNF839	491	A8K0R7
QPREKVSSIDLEIDS	ZYX	136	Q15942
EDDNPSASKILRRIS	TRMT9B	366	Q9P272
KPQSLESRERQKSSD	STMND1	96	H3BQB6
RTQVESLRPEKQSET	STRADB	11	Q9C0K7
PVDLKRRLDSITSSQ	KDR	956	P35968
ARNTVLRPSLGKTEE	WEE2	481	P0C1S8
DPQNKERASTKERTL	ERCC4	471	Q92889
VSSDVEVSSPKRQRL	ZNF423	606	Q2M1K9
EVREVTRKSVPRNSL	TOGARAM1	1471	Q9Y4F4
RRVKEENPEIAVSAS	STK39	406	Q9UEW8
RRDLNESPVKSFVSI	UIMC1	671	Q96RL1
ARKRAAAEQDVPSTL	SIGLEC11	591	Q96RL6
PSTAEADRDRLQLIK	WWC3	261	Q9ULE0
SIEQPLRRDKSEASI	ZNF134	101	P52741
RIVRAESELSPSEKA	TRPC4	21	Q9UBN4
SRSKAVTRLEAENIP	TRIM58	256	Q8NG06
EALTKQVDAPRERSL	TYW1B	316	Q6NUM6
REAARVLVRSTTPKS	TYSND1	376	Q2T9J0
EEDIPEISRLSISQK	THEG	96	Q9P2T0
QDDKASSRLLVRPTS	TRIO	1886	O75962
AERPERSVSTLKIQR	TRBV7-4	86	A0A1B0GX95
RDLDAITDISPKQST	ZKSCAN5	326	Q9Y2L8
TLDTPQLERKRTREL	UBR5	1966	O95071
DKRLRTTITPEQLEI	ZFHX3	2641	Q15911
SDVKLLAESLPRRNS	VPS13D	531	Q5THJ4
DPQTLTDTTEEKRRN	MYRIP	571	Q8NFW9
RSDAIPIVAAKASRD	NEB	3016	P20929